https://www.pharmaceutical-technology.com/data-insights/bct-100-bio-cancer-treatment-international-high-grade-glioma-likelihood-of-approval/ 2024-05-20T05:40:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/masitinib-ab-science-asthma-likelihood-of-approval/ 2024-04-23T03:38:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/bct-100-bio-cancer-treatment-international-sarcomas-likelihood-of-approval/ 2024-05-20T05:39:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/bct-100-bio-cancer-treatment-international-neuroblastoma-likelihood-of-approval/ 2024-05-20T05:39:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/afatinib-dimaleate-boehringer-ingelheim-international-refractory-multiple-myeloma-likelihood-of-approval/ 2024-04-23T03:37:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/bct-100-bio-cancer-treatment-international-acute-lymphocytic-leukemia-all-acute-lymphoblastic-leukemia-likelihood-of-approval/ 2024-05-20T05:39:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ensartinib-hydrochloride-betta-pharmaceuticals-non-small-cell-lung-cancer-likelihood-of-approval/ 2025-01-21T16:57:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/rec-4881-recursion-pharmaceuticals-colorectal-cancer-likelihood-of-approval/ 2024-04-23T03:37:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/tafasitamab-incyte-non-hodgkin-lymphoma-likelihood-of-approval/ 2025-01-21T16:57:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/rhenium-188p2045-andarix-pharmaceuticals-squamous-non-small-cell-lung-carcinoma-likelihood-of-approval/ 2025-01-21T16:57:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/pemafibrate-kowa-primary-biliary-cholangitis-primary-biliary-cirrhosis-likelihood-of-approval/ 2025-01-21T16:57:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/saroglitazar-zydus-lifesciences-hypertriglyceridemia-likelihood-of-approval/ 2024-04-23T03:35:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/anakinra-swedish-orphan-biovitrum-cytokine-release-syndrome-cytokine-storm-likelihood-of-approval/ 2025-01-21T16:57:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/mifepristone-corcept-therapeutics-triple-negative-breast-cancer-tnbc-likelihood-of-approval/ 2024-04-23T03:35:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/censavudine-transposon-therapeutics-amyotrophic-lateral-sclerosis-likelihood-of-approval/ 2025-01-21T16:56:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/censavudine-transposon-therapeutics-frontotemporal-dementia-ftd-likelihood-of-approval/ 2025-01-21T16:57:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/tezepelumab-amgen-churg-strauss-syndrome-likelihood-of-approval/ 2024-04-23T03:34:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/tezepelumab-amgen-cat-allergy-likelihood-of-approval/ 2025-01-21T16:56:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/enzalutamide-pfizer-refractory-chronic-lymphocytic-leukemia-cll-likelihood-of-approval/ 2024-09-09T05:57:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/sotagliflozin-lexicon-pharmaceuticals-hypertrophic-cardiomyopathy-likelihood-of-approval/ 2025-01-21T16:56:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/tremelimumab-astrazeneca-kidney-cancer-renal-cell-cancer-likelihood-of-approval/ 2025-01-21T16:56:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/enzalutamide-pfizer-relapsed-chronic-lymphocytic-leukemia-cll-likelihood-of-approval/ 2024-09-09T05:57:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/abexinostat-xynomic-pharmaceuticals-diffuse-large-b-cell-lymphoma-likelihood-of-approval/ 2024-04-23T03:32:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/abexinostat-xynomic-pharmaceuticals-mantle-cell-lymphoma-likelihood-of-approval/ 2024-04-23T03:32:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/naptumomab-estafenatox-neotx-therapeutics-non-small-cell-lung-cancer-likelihood-of-approval/ 2024-04-23T03:32:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/hyaluronidase-recombinant-human-immune-globulin-human-takeda-pharmaceutical-lymphoma-likelihood-of-approval/ 2024-07-05T18:26:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/blinatumomab-amgen-acute-lymphocytic-leukemia-all-acute-lymphoblastic-leukemia-likelihood-of-approval/ 2025-01-21T16:56:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/daratumumab-johnson-johnson-refractory-chronic-lymphocytic-leukemia-cll-likelihood-of-approval/ 2024-04-23T03:31:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/lenvatinib-mesylate-eisai-bladder-cancer-likelihood-of-approval/ 2025-01-21T16:56:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/neratinib-puma-biotechnology-non-small-cell-lung-cancer-likelihood-of-approval/ 2024-09-09T05:57:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/jnj-79032421-johnson-johnson-peritoneal-cancer-likelihood-of-approval/ 2024-06-19T16:05:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/jnj-79032421-johnson-johnson-epithelial-ovarian-cancer-likelihood-of-approval/ 2024-06-19T16:05:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/jnj-79032421-johnson-johnson-malignant-mesothelioma-likelihood-of-approval/ 2024-06-19T16:05:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/jnj-79032421-johnson-johnson-pancreatic-ductal-adenocarcinoma-likelihood-of-approval/ 2024-06-19T16:05:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/nn-9931-novo-nordisk-metabolic-dysfunction-associated-steatohepatitis-mash-likelihood-of-approval/ 2025-01-21T16:56:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/jnj-79032421-johnson-johnson-fallopian-tube-cancer-likelihood-of-approval/ 2024-06-19T16:05:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/na-931-biomed-industries-obesity-likelihood-of-approval/ 2024-04-23T03:28:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/nn-9931-novo-nordisk-liver-cirrhosis-likelihood-of-approval/ 2024-04-23T03:28:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/aaa-604-novartis-solid-tumor-likelihood-of-approval/ 2025-01-21T16:56:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/stemvacs-a-therapeutic-solutions-international-solid-tumor-likelihood-of-approval/ 2024-04-23T03:28:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/rg-6468-genentech-usa-solid-tumor-likelihood-of-approval/ 2024-04-23T03:27:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/pf-08046045-pfizer-solid-tumor-likelihood-of-approval/ 2025-01-21T16:55:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/rg-6457-f-hoffmann-la-roche-solid-tumor-likelihood-of-approval/ 2024-04-23T03:27:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/sq-009-seqirus-influenzavirus-a-infections-likelihood-of-approval/ 2024-04-23T03:27:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/nt-112-neogene-therapeutics-non-small-cell-lung-cancer-likelihood-of-approval/ 2025-01-21T16:55:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/nt-112-neogene-therapeutics-pancreatic-ductal-adenocarcinoma-likelihood-of-approval/ 2025-01-21T16:55:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/nt-112-neogene-therapeutics-solid-tumor-likelihood-of-approval/ 2025-01-21T16:55:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/nt-112-neogene-therapeutics-endometrial-cancer-likelihood-of-approval/ 2025-01-21T16:55:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/rp-1664-repare-therapeutics-solid-tumor-likelihood-of-approval/ 2024-04-23T03:25:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/nt-112-neogene-therapeutics-colorectal-cancer-likelihood-of-approval/ 2025-01-21T16:55:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/platelet-coupled-il-2-cell-injection-zcapsule-pharmaceuticals-shaoxing-solid-tumor-likelihood-of-approval/ 2025-01-21T16:55:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/xl-309-exelixis-solid-tumor-likelihood-of-approval/ 2025-01-21T16:55:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/am-003-aummune-therapeutics-soft-tissue-sarcoma-likelihood-of-approval/ 2025-01-21T16:55:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/am-003-aummune-therapeutics-metastatic-colorectal-cancer-likelihood-of-approval/ 2025-01-21T16:55:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/am-003-aummune-therapeutics-thyroid-cancer-likelihood-of-approval/ 2025-01-21T16:55:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/am-003-aummune-therapeutics-nonmelanomatous-skin-cancer-likelihood-of-approval/ 2025-01-21T16:55:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/am-003-aummune-therapeutics-metastatic-melanoma-likelihood-of-approval/ 2025-01-21T16:54:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/am-003-aummune-therapeutics-solid-tumor-likelihood-of-approval/ 2025-01-21T16:55:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/vio-01-valerio-therapeutics-triple-negative-breast-cancer-tnbc-likelihood-of-approval/ 2024-04-23T03:22:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/am-003-aummune-therapeutics-head-and-neck-cancer-likelihood-of-approval/ 2025-01-21T16:54:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/vio-01-valerio-therapeutics-metastatic-ovarian-cancer-likelihood-of-approval/ 2024-04-23T03:22:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/vio-01-valerio-therapeutics-metastatic-prostate-cancer-likelihood-of-approval/ 2024-04-23T03:22:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/vio-01-valerio-therapeutics-metastatic-breast-cancer-likelihood-of-approval/ 2024-04-23T03:21:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/vio-01-valerio-therapeutics-solid-tumor-likelihood-of-approval/ 2024-04-23T03:21:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ct-0525-ctx-operations-gastroesophageal-ge-junction-carcinomas-likelihood-of-approval/ 2024-04-23T03:21:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ct-0525-ctx-operations-human-epidermal-growth-factor-receptor-2-positive-breast-cancer-her2-breast-cancer-likelihood-of-approval/ 2024-04-23T03:21:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/npx-887-nextpoint-therapeutics-non-small-cell-lung-carcinoma-likelihood-of-approval/ 2024-04-23T03:20:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ct-0525-ctx-operations-solid-tumor-likelihood-of-approval/ 2024-04-23T03:20:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/npx-887-nextpoint-therapeutics-metastatic-renal-cell-carcinoma-likelihood-of-approval/ 2024-04-23T03:20:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/npx-887-nextpoint-therapeutics-lung-adenocarcinoma-likelihood-of-approval/ 2024-04-23T03:20:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/npx-887-nextpoint-therapeutics-solid-tumor-likelihood-of-approval/ 2024-04-23T03:19:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/npx-887-nextpoint-therapeutics-metastatic-colorectal-cancer-likelihood-of-approval/ 2024-04-23T03:19:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ly-3841136-eli-lilly-and-co-obesity-likelihood-of-approval/ 2024-04-23T03:19:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/npx-887-nextpoint-therapeutics-small-cell-lung-cancer-likelihood-of-approval/ 2024-04-23T03:19:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/bms-986406-bristol-myers-squibb-triple-negative-breast-cancer-tnbc-likelihood-of-approval/ 2024-04-23T03:18:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ibi-133-innovent-biologics-solid-tumor-likelihood-of-approval/ 2025-01-21T16:54:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/afnt-211-affini-t-therapeutics-non-small-cell-lung-cancer-likelihood-of-approval/ 2024-09-09T05:56:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/afnt-211-affini-t-therapeutics-pancreatic-ductal-adenocarcinoma-likelihood-of-approval/ 2024-09-09T05:56:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/afnt-211-affini-t-therapeutics-colorectal-cancer-likelihood-of-approval/ 2024-09-09T05:56:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/afnt-211-affini-t-therapeutics-solid-tumor-likelihood-of-approval/ 2024-09-09T05:56:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ono-7122-ono-pharmaceutical-solid-tumor-likelihood-of-approval/ 2024-06-19T16:04:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/gs-6212-gilead-sciences-human-immunodeficiency-virus-hiv-infections-aids-likelihood-of-approval/ 2024-04-23T03:16:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ast-001-ascentawits-pharmaceuticals-rectal-cancer-likelihood-of-approval/ 2024-07-05T18:23:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ast-001-ascentawits-pharmaceuticals-esophageal-cancer-likelihood-of-approval/ 2024-07-05T18:23:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ast-001-ascentawits-pharmaceuticals-renal-cell-carcinoma-likelihood-of-approval/ 2024-07-05T18:23:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ast-001-ascentawits-pharmaceuticals-non-small-cell-lung-cancer-likelihood-of-approval/ 2024-07-05T18:23:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ast-001-ascentawits-pharmaceuticals-solid-tumor-likelihood-of-approval/ 2024-07-05T18:23:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ast-001-ascentawits-pharmaceuticals-glioma-likelihood-of-approval/ 2024-07-05T18:23:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ast-001-ascentawits-pharmaceuticals-gastric-cancer-likelihood-of-approval/ 2024-07-05T18:23:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ast-001-ascentawits-pharmaceuticals-hepatocellular-carcinoma-likelihood-of-approval/ 2024-07-05T18:23:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ast-001-ascentawits-pharmaceuticals-colon-cancer-likelihood-of-approval/ 2024-07-05T18:23:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ast-001-ascentawits-pharmaceuticals-pancreatic-cancer-likelihood-of-approval/ 2024-07-05T18:23:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ast-001-ascentawits-pharmaceuticals-breast-cancer-likelihood-of-approval/ 2024-07-05T18:23:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ast-001-ascentawits-pharmaceuticals-prostate-cancer-likelihood-of-approval/ 2024-07-05T18:23:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/imp-17-eikon-therapeutics-peritoneal-cancer-likelihood-of-approval/ 2024-04-23T03:13:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/imp-17-eikon-therapeutics-metastatic-castration-resistant-prostate-cancer-mcrpc-likelihood-of-approval/ 2024-04-23T03:13:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/imp-17-eikon-therapeutics-metastatic-breast-cancer-likelihood-of-approval/ 2024-04-23T03:12:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/imp-17-eikon-therapeutics-fallopian-tube-cancer-likelihood-of-approval/ 2024-04-23T03:12:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/gene-modified-cell-therapy-to-target-cd7-for-oncology-suzhou-fundamenta-therapeutics-t-cell-acute-lymphocytic-leukemia-t-cell-acute-lymphoblastic-leukaemia-likelihood-of-approval/ 2024-04-23T03:11:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/imp-17-eikon-therapeutics-ovarian-cancer-likelihood-of-approval/ 2024-04-23T03:11:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cusp-06-oncusp-therapeutics-ovarian-cancer-likelihood-of-approval/ 2025-01-21T16:54:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cusp-06-oncusp-therapeutics-solid-tumor-likelihood-of-approval/ 2025-01-21T16:54:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/qtx-3034-quanta-therapeutics-solid-tumor-likelihood-of-approval/ 2024-09-09T05:56:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/qtx-3034-quanta-therapeutics-endometrial-cancer-likelihood-of-approval/ 2024-09-09T05:56:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/qtx-3034-quanta-therapeutics-colorectal-cancer-likelihood-of-approval/ 2024-09-09T05:56:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/qtx-3034-quanta-therapeutics-pancreatic-cancer-likelihood-of-approval/ 2024-09-09T05:56:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/xbh-25-gv20-therapeutics-head-and-neck-squamous-cell-carcinoma-hnsc-likelihood-of-approval/ 2024-06-19T16:04:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/qtx-3034-quanta-therapeutics-lung-cancer-likelihood-of-approval/ 2024-04-23T03:09:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/xbh-25-gv20-therapeutics-adenocarcinoma-likelihood-of-approval/ 2024-06-19T16:04:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/xbh-25-gv20-therapeutics-bladder-carcinoma-likelihood-of-approval/ 2024-06-19T16:04:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/xbh-25-gv20-therapeutics-endometrial-cancer-likelihood-of-approval/ 2024-06-19T16:04:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/xbh-25-gv20-therapeutics-non-small-cell-lung-cancer-likelihood-of-approval/ 2024-06-19T16:04:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/tt-01488-transthera-sciences-nanjing-marginal-zone-b-cell-lymphoma-likelihood-of-approval/ 2024-06-19T16:04:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/xbh-25-gv20-therapeutics-melanoma-likelihood-of-approval/ 2024-06-19T16:04:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/tt-01488-transthera-sciences-nanjing-diffuse-large-b-cell-lymphoma-likelihood-of-approval/ 2024-06-19T16:04:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/tt-01488-transthera-sciences-nanjing-waldenstrom-macroglobulinemia-lymphoplasmacytic-lymphoma-likelihood-of-approval/ 2024-06-19T16:04:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/abbv-400-abbvie-squamous-non-small-cell-lung-cancer-likelihood-of-approval/ 2024-09-09T05:56:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/tt-01488-transthera-sciences-nanjing-chronic-lymphocytic-leukemia-cll-likelihood-of-approval/ 2024-06-19T16:04:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/abbv-400-abbvie-adenocarcinoma-of-the-gastroesophageal-junction-likelihood-of-approval/ 2024-09-09T05:56:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/abbv-400-abbvie-head-and-neck-squamous-cell-carcinoma-hnsc-likelihood-of-approval/ 2024-07-05T18:23:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/abbv-400-abbvie-solid-tumor-likelihood-of-approval/ 2024-09-09T05:56:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/abbv-400-abbvie-renal-cell-carcinoma-likelihood-of-approval/ 2024-09-09T05:56:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/abbv-400-abbvie-colorectal-cancer-likelihood-of-approval/ 2024-09-09T05:55:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/abbv-400-abbvie-gastric-cancer-likelihood-of-approval/ 2024-09-09T05:55:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/fmc-376-frontier-medicines-non-small-cell-lung-cancer-likelihood-of-approval/ 2024-04-23T03:04:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/fmc-376-frontier-medicines-metastatic-colorectal-cancer-likelihood-of-approval/ 2024-04-23T03:04:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/fmc-376-frontier-medicines-metastatic-pancreatic-cancer-likelihood-of-approval/ 2024-04-23T03:04:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/fmc-376-frontier-medicines-solid-tumor-likelihood-of-approval/ 2024-04-23T03:04:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/olx-75016-olix-pharmaceuticals-metabolic-dysfunction-associated-steatohepatitis-mash-likelihood-of-approval/ 2024-07-05T18:22:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/olx-75016-olix-pharmaceuticals-metabolic-dysfunction-associated-steatotic-liver-disease-masld-likelihood-of-approval/ 2024-07-05T18:22:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/olomorasib-eli-lilly-and-co-non-small-cell-lung-cancer-likelihood-of-approval/ 2024-06-19T16:03:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/olx-75016-olix-pharmaceuticals-liver-cirrhosis-likelihood-of-approval/ 2024-07-05T18:22:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/olomorasib-eli-lilly-and-co-solid-tumor-likelihood-of-approval/ 2024-06-19T16:03:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/olomorasib-eli-lilly-and-co-endometrial-cancer-likelihood-of-approval/ 2024-06-19T16:03:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/olomorasib-eli-lilly-and-co-colorectal-cancer-likelihood-of-approval/ 2024-06-19T16:02:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/olomorasib-eli-lilly-and-co-pancreatic-cancer-likelihood-of-approval/ 2024-06-19T16:03:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cpi-300-coordination-pharmaceuticals-solid-tumor-likelihood-of-approval/ 2024-04-23T03:01:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/olomorasib-eli-lilly-and-co-ovarian-cancer-likelihood-of-approval/ 2024-06-19T16:02:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/pro-1107-profoundbio-suzhou-triple-negative-breast-cancer-tnbc-likelihood-of-approval/ 2024-04-23T03:01:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/pro-1107-profoundbio-suzhou-esophageal-squamous-cell-carcinoma-escc-likelihood-of-approval/ 2024-04-23T03:01:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/pro-1107-profoundbio-suzhou-peritoneal-cancer-likelihood-of-approval/ 2024-04-23T13:27:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/pro-1107-profoundbio-suzhou-epithelial-ovarian-cancer-likelihood-of-approval/ 2024-04-23T03:00:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/pro-1107-profoundbio-suzhou-adenocarcinoma-of-the-gastroesophageal-junction-likelihood-of-approval/ 2024-04-23T02:59:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/pro-1107-profoundbio-suzhou-ureter-cancer-likelihood-of-approval/ 2024-04-23T03:00:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/spurred-by-rise-in-deals-experts-say-adc-innovation-is-set-to-advance/ 2024-04-22T17:25:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/hyundai-to-advance-cancer-study-plans-for-niclosamide-based-drug/ 2024-04-22T16:12:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/tymlos-outperforms-teriparatide-real-world-fracture-analysis/ 2024-04-22T14:39:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/chiesi-champions-new-inhaler-propellant-to-reduce-carbon-footprint/ 2024-04-22T17:15:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/silence-therapeutics-gets-grant-for-compound-for-rna-interference-therapy-in-liver-disease/ 2024-04-22T12:28:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/syros-pharmaceuticals-gets-grant-for-cdk7-inhibitors-for-treating-cancer-and-other-diseases/ 2024-04-22T12:27:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/biomarin-pharmaceutical-gets-grant-for-treatment-of-adolescent-pku-patients-using-avpal-variant/ 2024-04-22T12:27:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ultragenyx-pharmaceutical-gets-grant-for-method-of-developing-stable-cell-line-for-producing-raav/ 2024-04-22T12:27:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/united-laboratories-international-gets-grant-for-jak-inhibitor-compound-for-treating-jak1-tyk2-related-diseases/ 2024-04-22T12:27:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/eurofins-scientific-gets-grant-for-method-to-detect-cancer-in-human-individual-using-cell-free-dna/ 2024-04-22T12:26:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/arvinas-gets-grant-for-bifunctional-compounds-for-modulating-tau-protein/ 2024-04-22T12:26:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/teladoc-health-gets-grant-for-contextual-video-searching-method-for-telepresence-devices/ 2024-04-22T12:26:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/purdue-pharma-gets-grant-for-treatment-of-t-cell-prolymphocytic-leukemia-using-tinostamustine/ 2024-04-22T12:26:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/genexine-gets-grant-for-treatment-of-hpv-induced-cancer-using-combination-of-hpv-vaccine-and-checkpoint-inhibitor/ 2024-04-22T12:25:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/esperion-therapeutics-gets-grant-for-preserving-and-administering-pre-beta-high-density-lipoprotein-plasma/ 2024-04-22T12:25:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/allakos-gets-grant-for-anti-siglec-7-antibody-with-reduced-effector-function-for-cancer-treatment/ 2024-04-22T12:25:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/csl-gets-grant-for-adjuvanted-influenza-vaccine-for-reducing-elderly-hospitalization-for-respiratory-illness/ 2024-04-22T12:25:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/chong-kun-dang-pharmaceutical-gets-grant-for-pharmaceutical-composition-for-gastritis-peptic-ulcer-treatment-using-cinnamomum-cassia-extract/ 2024-04-22T12:24:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/angelini-gets-grant-for-parcel-handling-and-tracking-system-with-light-permeable-scanning-window/ 2024-04-22T12:24:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/zealand-pharma-gets-grant-for-novel-acylated-glucagon-analogue-peptides-for-treating-metabolic-disorders-2/ 2024-04-22T12:24:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/sun-pharmaceutical-industries-gets-grant-for-hair-loss-treatment-using-jak1-jak2-inhibitor-compound/ 2024-04-22T12:24:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ptc-therapeutics-gets-grant-for-treatment-of-huntington-s-disease-using-compound-of-formula-ibbl-2/ 2024-04-22T12:23:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/senju-pharmaceutical-gets-grant-for-treatment-of-retinal-and-nerve-diseases-with-laminin-and-cells/ 2024-04-22T12:23:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/enanta-pharmaceuticals-gets-grant-for-inhibiting-coronavirus-replication-with-compound-of-formula-i-2/ 2024-04-22T12:23:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/indivior-gets-grant-for-medication-mixing-system-with-female-and-male-syringes/ 2024-04-22T12:23:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/arbutus-biopharma-gets-grant-for-method-of-treating-infusion-reaction-with-lipid-formulated-therapeutic-agent/ 2024-04-22T12:22:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/orexo-gets-grant-for-patent-granted-for-nasal-delivery-of-opioid-antagonist/ 2024-04-22T12:22:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/sorrento-therapeutics-gets-grant-for-implantable-device-for-delivering-bioactive-agents-without-immune-response/ 2024-04-22T12:22:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/zhejiang-huahai-pharmaceutical-gets-grant-for-method-for-preparing-pregabalin-using-biological-enzymes/ 2024-04-22T12:22:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ardelyx-gets-grant-for-compound-inhibiting-enzyme-11-hsd2-for-treating-hyperkalemia/ 2024-04-22T12:21:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/biogaia-gets-grant-for-lactic-acid-bacterial-strains-producing-melatonin-for-therapeutic-uses/ 2024-04-22T12:21:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/protagonist-therapeutics-gets-grant-for-peptide-inhibitors-for-treating-inflammatory-bowel-disease-2/ 2024-04-22T12:21:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/shilpa-medicare-gets-grant-for-pharmaceutical-liposomal-composition-with-docetaxel-for-cancer-treatment-2/ 2024-04-22T12:21:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/immunogen-gets-grant-for-immunoconjugates-binding-to-cd123-antigen-for-treating-diseases/ 2024-04-22T12:20:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/eli-lilly-and-co-gets-grant-for-patent-granted-for-mapt-rnai-agent-for-tauopathy-treatment/ 2024-04-22T12:20:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/iovance-biotherapeutics-gets-grant-for-gene-edited-til-composition-with-enhanced-ifn-secretion/ 2024-04-22T12:20:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/iveric-bio-gets-grant-for-nucleic-acid-therapeutic-for-complement-related-disorders/ 2024-04-22T12:19:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/radius-health-gets-grant-for-patent-granted-for-treating-prader-willi-syndrome-with-cannabidiol-formulation/ 2024-04-22T12:19:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/teva-pharmaceutical-industries-gets-grant-for-inhaler-with-lock-system-for-inhalable-substances/ 2024-04-22T12:19:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/voyager-therapeutics-gets-grant-for-enhanced-aav-capsid-for-brain-cell-targeting-2/ 2024-04-22T12:19:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/elanco-animal-health-gets-grant-for-eye-drop-composition-for-herpetic-eye-infections-in-animals/ 2024-04-22T12:18:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/gsk-gets-grant-for-treatment-of-lung-cancer-with-tim-3-binding-agents/ 2024-04-22T12:18:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/aldeyra-therapeutics-gets-grant-for-treatment-of-retinitis-pigmentosa-with-methotrexate-eye-injections/ 2024-04-22T12:18:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/pmv-pharmaceuticals-gets-grant-for-compounds-restoring-dna-binding-affinity-of-p53-mutants/ 2024-04-22T12:18:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/avidity-biosciences-gets-grant-for-polynucleic-acid-conjugate-for-treating-fshd-through-rna-interference/ 2024-04-22T12:17:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/synlogic-gets-grant-for-genetically-engineered-bacteria-for-attenuating-metabolic-diseases/ 2024-04-22T12:17:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/wave-life-sciences-gets-grant-for-improved-method-for-synthesizing-phosphoramidites-with-higher-yields-and-purities-2/ 2024-04-22T12:17:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ose-immunotherapeutics-gets-grant-for-humanized-monoclonal-antibodies-targeting-cd127-for-therapeutic-and-diagnostic-use/ 2024-04-22T12:17:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ovid-therapeutics-gets-grant-for-treatment-of-status-epilepticus-with-ganaxolone-continuous-intravenous-infusion/ 2024-04-22T12:16:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/spruce-biosciences-gets-grant-for-treatment-of-polycystic-ovary-syndrome-with-adrenal-hyperandrogenism-2/ 2024-04-22T12:16:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/recursion-pharmaceuticals-gets-grant-for-pharmaceutical-compounds-for-treating-diseases/ 2024-04-22T12:16:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/abcellera-biologics-gets-grant-for-enhanced-production-of-diverse-antibodies-using-genetically-modified-mice/ 2024-04-22T12:16:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/pieris-pharmaceuticals-gets-grant-for-fusion-polypeptide-binding-cd137-and-gpc3-for-cancer-treatment/ 2024-04-22T12:15:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/takeda-astellas-smbc-jv/ 2024-04-22T10:43:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/health-canada-nora-niopeg/ 2024-04-22T10:46:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/bioarctic-eisai-alzheimers-treatment/ 2024-04-22T08:54:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/health-canada-merck-keytruda-cancer/ 2024-04-22T08:44:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/pro-1107-profoundbio-suzhou-transitional-cell-cancer-urothelial-cell-cancer-likelihood-of-approval/ 2024-04-20T05:01:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/pro-1107-profoundbio-suzhou-fallopian-tube-cancer-likelihood-of-approval/ 2024-04-20T05:01:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/pro-1107-profoundbio-suzhou-non-small-cell-lung-cancer-likelihood-of-approval/ 2024-04-20T05:01:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/pro-1107-profoundbio-suzhou-endometrial-cancer-likelihood-of-approval/ 2024-04-20T05:00:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/pro-1107-profoundbio-suzhou-solid-tumor-likelihood-of-approval/ 2024-04-20T05:00:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/pro-1107-profoundbio-suzhou-bladder-cancer-likelihood-of-approval/ 2024-04-20T05:00:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/pro-1107-profoundbio-suzhou-gastric-cancer-likelihood-of-approval/ 2024-04-20T05:00:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/df-4101-abbvie-head-and-neck-squamous-cell-carcinoma-hnsc-likelihood-of-approval/ 2024-04-20T04:59:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/df-4101-abbvie-non-small-cell-lung-cancer-likelihood-of-approval/ 2024-04-20T04:59:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/df-4101-abbvie-renal-cell-carcinoma-likelihood-of-approval/ 2024-04-20T04:59:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/df-4101-abbvie-solid-tumor-likelihood-of-approval/ 2024-04-20T04:58:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/rg-6315-genentech-usa-inflammation-likelihood-of-approval/ 2024-06-19T16:01:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/gh-21-huya-bioscience-international-non-small-cell-lung-cancer-likelihood-of-approval/ 2024-04-20T04:58:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/hu-6-rivus-pharmaceuticals-hypertriglyceridemia-likelihood-of-approval/ 2024-04-20T04:58:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/lirafugratinib-hydrochloride-relay-therapeutics-human-epidermal-growth-factor-receptor-2-negative-breast-cancer-her2-breast-cancer-likelihood-of-approval/ 2024-04-20T04:57:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/pf-08046054-pfizer-non-small-cell-lung-cancer-likelihood-of-approval/ 2024-04-20T04:57:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/pf-08046054-pfizer-gastric-cancer-likelihood-of-approval/ 2024-07-05T18:21:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/sigvotatug-vedotin-pfizer-non-small-cell-lung-cancer-likelihood-of-approval/ 2025-01-21T16:53:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/agent-797-mink-therapeutics-adenocarcinoma-of-the-gastroesophageal-junction-likelihood-of-approval/ 2025-01-21T16:53:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/agent-797-mink-therapeutics-esophageal-cancer-likelihood-of-approval/ 2025-01-21T16:53:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/p-muc1c-allo1-poseida-therapeutics-triple-negative-breast-cancer-tnbc-likelihood-of-approval/ 2024-04-20T04:55:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/p-muc1c-allo1-poseida-therapeutics-non-small-cell-lung-cancer-likelihood-of-approval/ 2024-04-20T04:55:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/p-muc1c-allo1-poseida-therapeutics-pancreatic-cancer-likelihood-of-approval/ 2024-07-05T18:21:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/sudocetaxel-zendusortide-theratechnologies-triple-negative-breast-cancer-tnbc-likelihood-of-approval/ 2025-01-21T16:52:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/zb-131-zielbio-ovarian-cancer-likelihood-of-approval/ 2024-07-05T18:20:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/dexamethasone-sodium-phosphate-avm-biotechnology-mantle-cell-lymphoma-likelihood-of-approval/ 2024-04-20T04:53:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ociperlimab-beigene-squamous-non-small-cell-lung-cancer-likelihood-of-approval/ 2024-04-20T04:53:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/vaxinia-imugene-metastatic-melanoma-likelihood-of-approval/ 2024-09-09T05:55:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/imsa-101-immunesensor-therapeutics-uveal-melanoma-likelihood-of-approval/ 2025-01-21T16:52:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/vaxinia-imugene-pancreatic-cancer-likelihood-of-approval/ 2024-09-09T05:55:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/inaticabtagene-autoleucel-juventas-cell-therapy-acquired-autoimmune-hemolytic-anemia-likelihood-of-approval/ 2025-01-21T16:52:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/rilvegostomig-astrazeneca-hepatocellular-carcinoma-likelihood-of-approval/ 2025-01-21T16:52:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/golcadomide-hydrochloride-bristol-myers-squibb-primary-cns-lymphoma-likelihood-of-approval/ 2024-09-09T05:53:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/golcadomide-hydrochloride-bristol-myers-squibb-primary-mediastinal-b-cell-lymphoma-likelihood-of-approval/ 2025-01-21T16:52:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/golcadomide-hydrochloride-bristol-myers-squibb-diffuse-large-b-cell-lymphoma-likelihood-of-approval/ 2025-01-21T16:52:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/golcadomide-hydrochloride-bristol-myers-squibb-follicular-lymphoma-likelihood-of-approval/ 2024-04-20T04:51:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/golcadomide-hydrochloride-bristol-myers-squibb-non-hodgkin-lymphoma-likelihood-of-approval/ 2024-09-09T05:53:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/polzastobart-concentra-biosciences-pleomorphic-liposarcoma-likelihood-of-approval/ 2024-07-05T18:20:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/dazostinag-takeda-pharmaceutical-oropharyngeal-cancer-likelihood-of-approval/ 2024-05-20T05:29:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/aaa-614-novartis-human-epidermal-growth-factor-receptor-2-negative-breast-cancer-her2-breast-cancer-likelihood-of-approval/ 2025-01-21T16:52:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/aaa-614-novartis-triple-negative-breast-cancer-tnbc-likelihood-of-approval/ 2025-01-21T16:52:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/aaa-614-novartis-non-small-cell-lung-cancer-likelihood-of-approval/ 2025-01-21T16:51:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/aaa-614-novartis-human-epidermal-growth-factor-receptor-2-positive-breast-cancer-her2-breast-cancer-likelihood-of-approval/ 2025-01-21T16:52:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/s-65487-les-laboratoires-servier-relapsed-multiple-myeloma-likelihood-of-approval/ 2024-09-09T05:53:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ao-176-arch-oncology-refractory-multiple-myeloma-likelihood-of-approval/ 2024-04-20T04:47:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/camonsertib-repare-therapeutics-relapsed-chronic-lymphocytic-leukemia-cll-likelihood-of-approval/ 2024-09-09T05:53:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/camonsertib-repare-therapeutics-refractory-chronic-lymphocytic-leukemia-cll-likelihood-of-approval/ 2024-09-09T05:53:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/io-202-immune-onc-therapeutics-chronic-myelomonocytic-leukemia-cmml-likelihood-of-approval/ 2024-04-20T04:46:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/subasumstat-takeda-pharmaceutical-cervical-cancer-likelihood-of-approval/ 2024-06-19T15:59:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/yeneo-001-nantbioscience-triple-negative-breast-cancer-tnbc-likelihood-of-approval/ 2024-04-20T04:45:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ulixacaltamide-hydrochloride-praxis-precision-medicines-essential-tremor-likelihood-of-approval/ 2025-01-21T16:51:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/yeneo-001-nantbioscience-non-small-cell-lung-cancer-likelihood-of-approval/ 2024-04-20T04:45:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/bdb-001-eikon-therapeutics-squamous-non-small-cell-lung-cancer-likelihood-of-approval/ 2024-04-20T04:45:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/adg-106-adagene-suzhou-triple-negative-breast-cancer-tnbc-likelihood-of-approval/ 2025-01-21T16:51:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/pimicotinib-abbisko-therapeutics-pancreatic-cancer-likelihood-of-approval/ 2024-07-05T18:19:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ksq-001-ksq-therapeutics-head-and-neck-squamous-cell-carcinoma-hnsc-likelihood-of-approval/ 2024-09-09T05:52:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/giredestrant-genentech-usa-breast-cancer-likelihood-of-approval/ 2025-01-21T16:51:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ksq-001-ksq-therapeutics-solid-tumor-likelihood-of-approval/ 2024-09-09T05:52:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ksq-001-ksq-therapeutics-non-small-cell-lung-cancer-likelihood-of-approval/ 2024-09-09T05:52:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ksq-001-ksq-therapeutics-metastatic-melanoma-likelihood-of-approval/ 2024-09-09T05:52:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/rigosertib-sodium-traws-pharma-squamous-cell-carcinoma-likelihood-of-approval/ 2024-04-20T00:28:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/js-006-shanghai-junshi-biosciences-non-small-cell-lung-cancer-likelihood-of-approval/ 2024-04-19T17:24:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/js-006-shanghai-junshi-biosciences-hepatocellular-carcinoma-likelihood-of-approval/ 2024-04-19T17:23:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/js-006-shanghai-junshi-biosciences-solid-tumor-likelihood-of-approval/ 2024-04-19T17:23:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/rhenium-186re-obisbemeda-plus-therapeutics-head-and-neck-cancer-likelihood-of-approval-3/ 2024-04-19T17:14:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/alvotech-moves-to-bring-its-humira-biosimilar-to-us-market/ 2024-04-19T17:13:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/fhnd-71-protheragen-solid-tumor-likelihood-of-approval/ 2024-04-19T17:04:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/xh-001-neocura-bio-medical-technology-solid-tumor-likelihood-of-approval/ 2024-04-19T17:04:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/vertexs-pain-drug-suzetrigine-advances-in-fda-approval-process/ 2024-04-19T16:20:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/roche-wins-second-fda-label-expansion-for-alecensa-in-nsclc/ 2024-04-19T16:10:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/inhibikase-sees-opportunity-in-cardiopulmonary-disease-for-ikt-001pro/ 2024-04-19T16:07:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/interviews/qa-cell-and-gene-therapy-value-assessments-need-a-rework-to-allow-access/ 2024-05-08T09:26:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/askbio-fda-fast-track-status/ 2024-04-19T10:32:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/evotec-antifibrotic-drug-discovery/ 2024-04-19T10:31:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nih-ai-tool-drug-response/ 2024-04-19T08:40:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-takeda-entyvio-sc/ 2024-04-19T09:06:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/the-next-phase-for-mrna-looking-beyond-covid-19/ 2024-04-19T08:17:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/rigosertib-sodium-traws-pharma-epidermolysis-bullosa-likelihood-of-approval/ 2024-04-19T01:17:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/dexborneol-edaravone-neurodawn-pharmaceutical-acute-ischemic-stroke-likelihood-of-approval/ 2024-04-19T00:07:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/weekly-insulin-analogues-approaching-approval-could-herald-change/ 2024-04-18T17:47:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/lack-of-harmonisation-in-europe-hindering-gene-therapy-growth/ 2024-04-25T15:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/chemomab-touts-study-confirming-ccl24-link-to-systemic-sclerosis-severity/ 2024-04-18T16:05:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/oncox-inks-licensing-deal-worth-over-26m-for-nsclc-therapy/ 2024-04-18T15:46:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/inflammation-among-current-dementia-research-focus-says-alchemab-cso/ 2024-04-18T14:08:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/buyers-guide/clinical-trial-services/ 2025-11-05T11:38:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/denali-therapeutics-gets-grant-for-polypeptides-targeting-transferrin-receptor-for-brain-delivery/ 2024-04-18T12:11:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cue-biopharma-gets-grant-for-fusion-polypeptide-with-variant-il-2-and-antibody-fc-region/ 2024-04-18T12:11:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/tenaya-therapeutics-gets-grant-for-compound-for-treating-diseases-by-inhibiting-hdac6-activity/ 2024-04-18T12:11:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/rapt-therapeutics-gets-grant-for-inhibiting-hematopoietic-progenitor-kinase-1-using-pyrazole-pyrimidine-compounds/ 2024-04-18T12:11:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ikena-oncology-gets-grant-for-cancer-treatment-method-using-compounds-of-formula-i/ 2024-04-18T12:11:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/vir-biotechnology-gets-grant-for-multispecific-antibodies-for-zika-virus-infection-treatment/ 2024-04-18T12:11:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/foghorn-therapeutics-gets-grant-for-compounds-for-treating-baf-complex-related-disorders-2/ 2024-04-18T12:11:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/huadong-medicine-gets-grant-for-multi-domain-active-protein-for-treating-metabolic-diseases/ 2024-04-18T12:11:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/sword-health-gets-grant-for-method-for-synchronizing-timestamps-from-embedded-wireless-data-sensors/ 2024-04-18T12:11:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/aligos-therapeutics-gets-grant-for-treatment-of-disease-using-compounds-of-formula-i-2/ 2024-04-18T12:11:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/vericel-gets-grant-for-cartilage-repair-composition-using-cultured-allogeneic-chondrocytes-on-collagen-membrane/ 2024-04-18T12:11:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cytokinetics-gets-grant-for-pharmaceutical-compounds-for-medical-use/ 2024-04-18T12:10:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/medipal-gets-grant-for-temperature-monitoring-and-quality-certification-system-for-delivered-articles/ 2024-04-18T12:10:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/genmab-gets-grant-for-patent-granted-for-novel-bispecific-antibodies-with-unique-fc-regions/ 2024-04-18T12:10:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/immunic-gets-grant-for-treatment-of-relapsing-remitting-multiple-sclerosis-with-vidofludimus/ 2024-04-18T12:10:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/kodiak-sciences-gets-grant-for-treating-eye-disorder-with-anti-vegf-antibody-conjugate/ 2024-04-18T12:10:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/epivax-gets-grant-for-patent-granted-for-t-cell-epitope-composition-to-suppress-immune-response/ 2024-04-18T12:10:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/shijiazhuang-yiling-pharmaceutical-gets-grant-for-gnrhr-antagonist-compound-with-improved-pharmacokinetic-properties/ 2024-04-18T12:10:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/nurix-therapeutics-gets-grant-for-degradation-of-btk-using-compound-of-formula-a-2/ 2024-04-18T12:10:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/verastem-gets-grant-for-dual-raf-mek-inhibitor-for-cancer-treatment-in-solid-form/ 2024-04-18T12:10:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/bluebird-bio-gets-grant-for-deriving-additional-features-from-input-data-using-semantic-information-2/ 2024-04-18T12:10:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/zhejiang-hisun-pharmaceutical-gets-grant-for-irak4-inhibitors-represented-by-indazole-derivatives-of-formula-i/ 2024-04-18T12:10:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/medicinova-gets-grant-for-ibudilast-tablet-or-capsule-formulations-with-higher-dosage/ 2024-04-18T12:10:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/wockhardt-gets-grant-for-treatment-of-bacterial-infection-using-nitrogen-containing-bicyclic-compounds/ 2024-04-18T12:10:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/therapeuticsmd-gets-grant-for-progesterone-formulation-for-oral-administration-with-reduced-dosage/ 2024-04-18T12:10:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/innate-pharma-gets-grant-for-patent-granted-for-antibodies-redirecting-nk-cells-to-target-cells/ 2024-04-18T12:10:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/lixte-biotechnology-gets-grant-for-in-vivo-delivery-of-endothall-to-cancer-cells-2/ 2024-04-18T12:10:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/replicel-life-sciences-gets-grant-for-injection-device-for-delivering-liquid-substance-into-tissue/ 2024-04-18T12:10:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/delcath-systems-gets-grant-for-optimizing-chemotherapeutic-agent-filtration-media-pair-for-cancer-treatment/ 2024-04-18T12:10:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/redhill-biopharma-gets-grant-for-treatment-of-coronavirus-infection-using-wx-671-composition/ 2024-04-18T12:10:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/trevena-gets-grant-for-pharmaceutical-composition-for-modulating-s1p1-receptor-activity/ 2024-04-18T12:10:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/inhibrx-gets-grant-for-immunoconjugate-comprising-vhh-domain-binding-cd123-and-cytotoxic-agent/ 2024-04-18T12:10:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/arrowhead-pharmaceuticals-gets-grant-for-dsrna-for-inhibiting-rrm2-gene-expression/ 2024-04-18T12:10:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/exicure-gets-grant-for-liposomal-particles-for-gene-regulation-with-spherical-geometry/ 2024-04-18T12:10:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/celldex-therapeutics-gets-grant-for-antibodies-for-treating-kit-associated-disorders/ 2024-04-18T12:10:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/navidea-biopharmaceuticals-gets-grant-for-method-for-conjugating-metal-chelating-agent-to-functionalized-dextran-2/ 2024-04-18T12:10:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/acer-therapeutics-gets-grant-for-crystalline-form-of-emetine-dihydrochloride-2/ 2024-04-18T12:10:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/actinium-pharmaceuticals-gets-grant-for-radiolabeled-anti-cd45-antibody-method-for-depleting-hematopoietic-stem-cells/ 2024-04-18T12:10:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/galecto-gets-grant-for-treatment-method-for-disorders-related-to-galectin-3-binding/ 2024-04-18T12:09:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/divi-s-laboratories-gets-grant-for-process-for-preparing-brivaracetam-from-r-4-propyl-pyrrolidine-2-one/ 2024-04-18T12:09:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/emcure-pharmaceuticals-gets-grant-for-ready-to-use-carmustine-solution-for-parenteral-administration-2/ 2024-04-18T12:09:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/editas-medicine-gets-grant-for-allele-specific-modification-of-hla-genes-for-cell-transplantation/ 2024-04-18T12:09:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/fate-therapeutics-gets-grant-for-method-for-generating-immune-regulatory-cells-with-enhanced-potential/ 2024-04-18T12:09:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/shenzhen-hepalink-pharmaceutical-group-gets-grant-for-pharmaceutical-composition-for-treating-metabolic-diseases-and-liver-disorders-2/ 2024-04-18T12:09:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/molecular-templates-gets-grant-for-pd-l1-binding-molecule-for-treating-cancer/ 2024-04-18T12:09:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/proqr-therapeutics-gets-grant-for-oligonucleotide-for-reducing-aberrant-splice-site-selection-in-cep290-gene/ 2024-04-18T12:09:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/crispr-therapeutics-gets-grant-for-masked-car-for-ptk7-with-therapeutic-uses/ 2024-04-18T12:09:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/agios-pharmaceuticals-gets-grant-for-phenylketonuria-treatment-compound/ 2024-04-18T12:09:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/intellia-therapeutics-gets-grant-for-genome-editing-system-for-immunooncology-2/ 2024-04-18T12:09:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/jaguar-health-gets-grant-for-treating-secretory-diarrhea-associated-with-microvillous-inclusion-disease/ 2024-04-18T12:09:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/outrun-therapeutics-e3-ligase-inhibitors/ 2024-04-18T10:24:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/clearmind-licenses-psychedelic-compounds/ 2024-04-18T10:38:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/the-importance-of-finidng-a-versatile-scalable-cdmo-in-the-softgel-market/ 2024-04-23T09:24:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/the-importance-of-ai-in-protecting-hospitals-from-cyberattacks/ 2024-04-18T08:30:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/theolytics-oncolytic-adenovirus-therapy/ 2024-04-18T08:52:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/essential-pharma-reminyl/ 2024-04-18T08:55:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/lonigutamab-ugodotin-laboratoires-pierre-fabre-soft-tissue-sarcoma-likelihood-of-approval/ 2025-01-22T18:08:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/igm-and-sanofi-collaboration-will-pivot-to-immunology-and-inflammation/ 2024-04-17T16:04:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/lexeo-wins-fast-track-designation-for-friedreichs-ataxia-gene-therapy/ 2024-04-18T10:10:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/eagle-pharmaceuticals-gets-grant-for-long-term-stable-bendamustine-containing-composition-in-sterile-vial-2/ 2024-04-17T12:36:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/beyondspring-gets-grant-for-treating-cancer-expressing-mutant-ras-protein-with-plinabulin/ 2024-04-17T12:36:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/gritstone-bio-gets-grant-for-method-of-identifying-cassette-sequence-for-neoantigen-vaccine/ 2024-04-17T12:36:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/decibel-therapeutics-gets-grant-for-hypertonic-pharmaceutical-composition-for-anti-platinum-chemoprotection-2/ 2024-04-17T12:36:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/corvus-pharmaceuticals-gets-grant-for-modulating-interleukin-2-inducible-t-cell-kinase/ 2024-04-17T12:36:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/oric-pharmaceuticals-gets-grant-for-plk4-inhibitors-for-treating-cancer/ 2024-04-17T12:36:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/unity-biotechnology-gets-grant-for-senolytic-agents-for-treating-age-related-eye-conditions/ 2024-04-17T12:36:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/kaleido-biosciences-gets-grant-for-glycan-therapeutic-preparation-for-reducing-gastrointestinal-inflammation-in-immune-imbalance/ 2024-04-17T12:36:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/tcr2-therapeutics-gets-grant-for-recombinant-nucleic-acid-encoding-tcr-fusion-protein-for-cancer-treatment-2/ 2024-04-17T12:36:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/wuxi-apptec-gets-grant-for-process-for-preparing-dichloroacetic-acid-composition-with-low-glyoxylic-acid/ 2024-04-17T12:36:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/pliant-therapeutics-gets-grant-for-treatment-of-fibrotic-diseases-using-av-6-integrin-inhibitors/ 2024-04-17T12:36:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/change-healthcare-gets-grant-for-database-record-labeling-and-ai-model-training-prioritization-method/ 2024-04-17T12:35:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/innocare-pharma-gets-grant-for-trk-inhibitors-for-treating-diseases-such-as-cancers-2/ 2024-04-17T12:35:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/springworks-therapeutics-gets-grant-for-treatment-of-desmoid-tumor-with-nirogacestat-in-specific-dosages/ 2024-04-17T12:35:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/albireo-pharma-gets-grant-for-treatment-of-diseases-with-specific-benzothiazepine-and-benzothiadiazepine-derivatives/ 2024-04-17T12:35:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/community-health-systems-gets-grant-for-portable-sleep-diagnostic-system-for-remote-sleep-apnea-testing/ 2024-04-17T12:35:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/hutchmed-china-gets-grant-for-treatment-of-cancer-with-triazolopyridines-and-triazolopyrazines/ 2024-04-17T12:35:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/boehringer-ingelheim-international-gets-grant-for-patent-granted-for-using-empagliflozin-to-reduce-heart-failure-risk/ 2024-04-17T12:35:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/alector-gets-grant-for-antibody-for-treating-an-individual-with-mertk-polypeptide/ 2024-04-17T12:35:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/children-s-medical-center-gets-grant-for-cleaning-central-venous-catheter-port-with-rotating-cleaning-cap/ 2024-04-17T12:35:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/constellation-pharmaceuticals-gets-grant-for-novel-compounds-for-treating-diseases-associated-with-methyl-modifying-enzymes/ 2024-04-17T12:35:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/mirati-therapeutics-gets-grant-for-combination-therapy-for-treating-kras-g12c-cancers/ 2024-04-17T12:35:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/allergan-gets-grant-for-hif-1a-prolyl-hydroxylase-inhibitors-for-treating-cardiovascular-diseases/ 2024-04-17T12:35:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ayala-pharmaceuticals-gets-grant-for-recombinant-fusion-polypeptides-for-cancer-immunotherapy/ 2024-04-17T12:35:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/global-blood-therapeutics-gets-grant-for-crystalline-form-of-compound-i-for-medical-use/ 2024-04-17T12:35:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/evogene-gets-grant-for-genetically-modified-bacterial-strain-for-insect-pest-control/ 2024-04-17T12:35:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/sartorius-stedim-biotech-gets-grant-for-multiparameter-lateral-flow-membrane-for-testing-multiple-analytes/ 2024-04-17T12:35:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/merck-gets-grant-for-semiconducting-nanoparticle-composition-with-antioxidant-for-optical-devices/ 2024-04-17T12:35:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/boston-children-s-hospital-gets-grant-for-modifying-hematopoietic-stem-cells-to-increase-pd-l1-expression/ 2024-04-17T12:35:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/zhejiang-medicine-gets-grant-for-method-for-extracting-and-isolating-lutein-crystal-from-vegetable-oil/ 2024-04-17T12:35:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/loxo-oncology-gets-grant-for-treatment-of-systemic-sclerosis-fibrosis-achondroplasia-cancer/ 2024-04-17T12:35:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/mitsubishi-tanabe-pharma-gets-grant-for-treatment-method-for-inflammatory-chronic-disease-using-sirna/ 2024-04-17T12:35:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/avadel-pharmaceuticals-gets-grant-for-patent-granted-for-modified-release-formulation-of-gamma-hydroxybutyrate/ 2024-04-17T12:35:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/antisense-therapeutics-gets-grant-for-treating-multiple-sclerosis-with-oligonucleotide-i/ 2024-04-17T12:35:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/geovax-labs-gets-grant-for-recombinant-mva-vector-for-generating-immune-response-to-hemorrhagic-viruses/ 2024-04-17T12:35:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/chugai-pharmaceutical-gets-grant-for-target-tissue-specific-antigen-binding-molecules-library/ 2024-04-17T12:35:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/siga-technologies-gets-grant-for-treatment-of-orthopoxvirus-infections-using-polymorph-form-i-of-st-246/ 2024-04-17T12:35:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/pds-biotechnology-gets-grant-for-vaccine-composition-with-cationic-lipid-for-immune-response-enhancement/ 2024-04-17T12:35:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/sichuan-kelun-pharmaceutical-gets-grant-for-preparation-method-for-antibody-drug-conjugate/ 2024-04-17T12:34:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/amneal-pharmaceuticals-gets-grant-for-gastroretentive-dosage-form-for-extended-release-of-pyridostigmine/ 2024-04-17T12:34:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/emergent-biosolutions-gets-grant-for-treatment-of-viral-infection-using-morphic-form-ii-phosphonic-acid/ 2024-04-17T12:34:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/unichem-laboratories-gets-grant-for-intermediate-for-efficient-preparation-of-rivaroxaban/ 2024-04-17T12:34:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/amryt-pharma-gets-grant-for-oral-octreotide-therapy-method-without-combined-oral-contraceptives/ 2024-04-17T12:34:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/chemocentryx-gets-grant-for-treatment-of-pancreatic-cancer-using-pharmaceutical-combinations/ 2024-04-17T12:34:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/amag-pharmaceuticals-gets-grant-for-microchip-for-measuring-clotting-time-in-blood-samples/ 2024-04-17T12:34:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/flatiron-health-gets-grant-for-machine-learning-for-extracting-clinical-variable-values-from-clinical-records/ 2024-04-17T12:34:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/immatics-biotechnologies-gets-grant-for-peptide-fvdnqywry-for-immunotherapy-of-cancer/ 2024-04-17T12:34:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/daewoong-pharmaceutical-gets-grant-for-crystalline-form-i-of-hydrochloride-preparation-method/ 2024-04-17T12:34:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/novavax-gets-grant-for-coronavirus-spike-proteins-for-stable-and-immunogenic-vaccines/ 2024-04-17T12:34:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/curevac-gets-grant-for-composition-for-covid-19-mrna-vaccine-in-lipid-nanoparticle/ 2024-04-17T12:34:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ultimovacs-downsizes-to-funnel-funds-to-cancer-vaccine-programme/ 2024-04-17T14:35:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/alvotech-teva-fda-selarsdi/ 2024-04-17T10:34:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/johnson-johnson-earnings-q1-2024/ 2024-04-17T10:28:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/tetrascience-google-cloud-partnership/ 2024-04-17T08:16:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/medincell-abbvie-injectable-therapy-deal/ 2024-04-17T08:55:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/nn-9931-novo-nordisk-net-present-value/ 2024-12-13T02:50:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ly-3972406-eli-lilly-and-co-net-present-value/ 2024-04-16T16:49:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/pf-07275315-pfizer-net-present-value/ 2024-04-16T16:49:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/azd-9574-astrazeneca-net-present-value/ 2024-04-16T16:48:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/nnc0519-0130-novo-nordisk-net-present-value/ 2024-07-02T02:14:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/sabestomig-astrazenecas-net-present-value/ 2024-04-17T05:34:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/abbv-400-abbvie-net-present-value/ 2024-07-02T02:14:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/mk-1084-merck-net-present-value/ 2024-05-16T02:01:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/tidal-01-turnstone-biologics-net-present-value/ 2024-07-02T02:14:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/olomorasib-eli-lilly-and-co-net-present-value/ 2024-04-16T16:48:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/sar-441566-sanofi-net-present-value/ 2024-07-02T02:05:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/azd-4604-astrazeneca-net-present-value/ 2024-07-02T02:14:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/nn-1845-novo-nordisk-net-present-value/ 2024-07-02T02:14:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cmg-901-astrazeneca-net-present-value/ 2024-06-13T18:47:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/tolerogenic-dna-novo-nordisk-net-present-value/ 2024-07-02T02:14:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/durcabtagene-autoleucel-novartis-net-present-value/ 2024-07-02T02:14:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/tulisokibart-merck-net-present-value/ 2024-12-13T02:53:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ocadusertib-eli-lilly-and-co-net-present-value/ 2024-07-02T02:13:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/rmc-6291-revolution-medicines-net-present-value/ 2024-05-16T02:00:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cemacabtagene-ansegedleucel-allogene-therapeutics-net-present-value/ 2024-06-13T18:56:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/azd-0780-astrazeneca-net-present-value/ 2024-04-16T16:47:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/auto-8-autolus-therapeutics-net-present-value/ 2024-12-13T02:53:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/pbgm-01-passage-bio-net-present-value/ 2024-07-02T02:13:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/pbft-02-passage-bio-net-present-value/ 2024-07-02T02:13:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/mk-2060-merck-net-present-value/ 2024-07-02T02:13:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/baxdrostat-astrazeneca-net-present-value/ 2024-07-02T02:13:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/hs-001-novo-nordisk-net-present-value/ 2024-07-02T02:13:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/zilovertamab-vedotin-merck-net-present-value/ 2024-07-02T02:13:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ucenprubart-eli-lilly-and-co-net-present-value/ 2024-07-02T02:13:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/mk-8527-merck-net-present-value/ 2024-04-16T16:47:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ak-otof-eli-lilly-and-co-net-present-value/ 2024-07-02T02:13:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/pt-101-merck-net-present-value/ 2024-07-02T02:13:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/bexotegrast-pliant-therapeutics-net-present-value/ 2024-07-02T02:05:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ponsegromab-pfizer-net-present-value/ 2024-07-02T02:13:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/boserolimab-merck-net-present-value/ 2024-07-02T02:13:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/mazdutide-eli-lilly-and-co-net-present-value/ 2024-07-02T02:12:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/abbv-383-abbvie-net-present-value/ 2024-06-13T18:56:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/decitabine-tetrahydrouridine-novo-nordisk-net-present-value/ 2024-04-16T16:46:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/bomedemstat-tosylate-merck-net-present-value/ 2024-12-13T02:53:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ucart-22-cellectis-net-present-value/ 2024-07-02T02:05:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/mezagitamab-takeda-pharmaceutical-net-present-value/ 2024-12-13T02:53:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/frexalimab-sanofi-net-present-value/ 2024-12-13T02:51:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/mk-8189-merck-net-present-value/ 2024-04-16T16:46:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/mk-4830-merck-net-present-value/ 2024-07-02T02:12:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/al-101-gsk-net-present-value/ 2024-12-13T02:53:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/onfasprodil-novartis-net-present-value/ 2024-04-16T16:45:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/bhv-7000-biohaven-net-present-value/ 2024-12-13T02:53:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/miransertib-mesylate-merck-net-present-value/ 2024-04-16T16:45:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/zigakibart-novartis-net-present-value/ 2024-06-13T18:55:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/efinopegdutide-merck-net-present-value/ 2024-07-02T02:12:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ak-1780-eli-lilly-and-co-net-present-value/ 2024-04-16T16:45:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/gsk-1070806-gsk-net-present-value/ 2024-12-13T02:53:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/harnessing-the-power-of-cell-and-gene-therapy-in-oncology/ 2024-04-16T16:27:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/jardiance-and-ofev-propel-boehringers-human-pharma-sales/ 2024-04-16T15:20:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/acorda-loses-nasdaq-listing-to-cap-biotechs-end/ 2024-04-16T14:51:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/harnessing-artificial-intelligence-and-digital-technologies-across-the-biopharma-value-chain/ 2024-10-16T10:29:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/two-major-breakthroughs-in-fragile-x-syndrome-treatments/ 2024-04-16T13:33:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/qureight-series-a-funding/ 2024-04-16T10:59:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-halts-neumoras-schizophrenia-drug-trial-over-convulsions-in-rabbits/ 2024-04-16T10:21:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-odd-novelmed-pnh/ 2024-04-16T10:41:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/india-sees-insignificant-revision-to-price-ceiling-in-2024/ 2024-04-16T09:23:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/norgine-high-risk-neuroblastoma/ 2024-04-16T08:37:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sanofi-mrna-vaccine-development/ 2024-05-30T08:01:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/the-cutting-edge-monitoring-technology-that-is-transforming-the-future-of-clinical-trials/ 2024-04-30T11:43:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/marinus-fails-to-meet-early-stopping-criteria-for-status-epilepticus-trial/ 2024-04-15T18:08:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/soligenix-bags-orpan-drug-designation-for-marburg-virus-vaccine/ 2024-04-15T15:36:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/aveo-pharmaceuticals-gets-grant-for-decreasing-blood-urea-nitrogen-levels-in-hyperuricemia-using-anti-gdf15-antibody/ 2024-04-15T13:16:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/allscripts-healthcare-solutions-gets-grant-for-resource-management-system-for-medical-software-applications-optimization/ 2024-04-15T13:16:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ferring-international-center-gets-grant-for-pharmaceutical-composition-for-treating-inflammatory-bowel-disease-using-bacteriophages/ 2024-04-15T13:16:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/arena-pharmaceuticals-gets-grant-for-treatment-of-atopic-dermatitis-with-compound-1/ 2024-04-15T13:16:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ablynx-gets-grant-for-inhibiting-tumor-growth-by-administering-polypeptides-binding-gitr/ 2024-04-15T13:16:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/immunitybio-gets-grant-for-cross-reactive-sars-cov2-vaccine-composition-for-multiple-coronaviruses/ 2024-04-15T13:16:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/atrium-health-gets-grant-for-cancer-treatment-using-antibodies-and-engineered-cytotoxic-cells/ 2024-04-15T13:16:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/zydus-lifesciences-gets-grant-for-oral-suspension-pharmaceutical-composition-of-immunosuppressive-agent/ 2024-04-15T13:16:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ginkgo-bioworks-gets-grant-for-aav-vector-for-treating-npc1-with-specific-gene-sequence/ 2024-04-15T13:16:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/genzyme-gets-grant-for-method-for-reducing-interference-in-drug-assay-due-to-antibodies/ 2024-04-15T13:16:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/heidelberg-pharma-gets-grant-for-treating-cancer-with-amino-substituted-amanitin-derivative-conjugates/ 2024-04-15T13:16:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/antares-pharma-gets-grant-for-injection-device-with-safety-features-for-medicament-delivery/ 2024-04-15T13:16:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/syndax-pharmaceuticals-gets-grant-for-inhibitors-of-menin-mll-interaction-for-cancer-treatment/ 2024-04-15T13:16:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cspc-pharmaceutical-group-gets-grant-for-pharmaceutical-formulation-for-treating-inflammatory-or-neurodegenerative-diseases/ 2024-04-15T13:16:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/larimar-therapeutics-gets-grant-for-fusion-protein-for-treating-non-nuclear-organelle-associated-disorders/ 2024-04-15T13:16:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/laboratoires-pierre-fabre-gets-grant-for-antibody-drug-conjugate-for-treating-breast-lung-and-kidney-cancer/ 2024-04-15T13:16:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/gw-pharmaceuticals-gets-grant-for-cbd-preparation-with-at-least-90-cbd-and-thc/ 2024-04-15T13:16:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/envision-healthcare-gets-grant-for-medical-imaging-distribution-system-with-prioritized-radiologist-queues/ 2024-04-15T13:16:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/principia-biopharma-gets-grant-for-modified-release-solid-oral-dosage-form-for-btk-inhibitor/ 2024-04-15T13:16:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/aileron-therapeutics-gets-grant-for-modified-cav-1-peptides-for-lung-infection-and-injury-treatment/ 2024-04-15T13:15:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/novo-nordisk-gets-grant-for-antibodies-binding-to-human-transthyretin-for-treating-ttr-amyloidosis/ 2024-04-15T13:15:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/taiho-pharmaceutical-gets-grant-for-method-for-treating-cancer-using-hsp90-inhibitor-and-other-agents/ 2024-04-15T13:15:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/halozyme-therapeutics-gets-grant-for-injection-device-with-safety-features-for-medicament-administration/ 2024-04-15T13:15:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/rocket-pharmaceuticals-gets-grant-for-gene-therapy-for-arrhythmogenic-cardiomyopathy-using-raav-vector/ 2024-04-15T13:15:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/botanix-pharmaceuticals-gets-grant-for-topical-treatment-for-dermatitis-with-cannabidiol-in-specific-composition/ 2024-04-15T13:15:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ipca-laboratories-gets-grant-for-intermediate-compound-for-synthesizing-rivaroxaban/ 2024-04-15T13:15:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/inflarx-gets-grant-for-treatment-of-hidradenitis-suppurativa-using-c5a-receptor-inhibitor/ 2024-04-15T13:15:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/nanthealth-gets-grant-for-patient-data-exchange-system-with-configurable-sensors-for-healthcare-providers/ 2024-04-15T13:15:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/mayo-clinic-gets-grant-for-improving-arteriovenous-fistula-maturation-and-functionality-using-senolytic-agents/ 2024-04-15T13:15:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/fresenius-kabi-usa-gets-grant-for-method-for-associating-and-managing-multiple-fluid-delivery-devices/ 2024-04-15T13:15:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ani-pharmaceuticals-gets-grant-for-powder-for-oral-suspension-with-hydrochlorothiazide-for-hypertension-treatment/ 2024-04-15T13:15:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/geisinger-gets-grant-for-predicting-mortality-risk-based-on-echocardiographic-video-using-neural-network/ 2024-04-15T13:15:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/alexion-pharmaceuticals-gets-grant-for-method-of-viral-filtration-for-recombinant-antibody-production/ 2024-04-15T13:15:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/genentech-usa-gets-grant-for-treatment-method-for-fibrotic-inflammatory-or-autoimmune-disorders-using-compound-i/ 2024-04-15T13:15:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/athersys-gets-grant-for-method-for-treating-cutaneous-burn-healing-using-non-embryonic-cells/ 2024-04-15T13:15:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/translate-bio-gets-grant-for-method-of-quantifying-mrna-capping-efficiency-during-manufacturing/ 2024-04-15T13:15:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/celgene-gets-grant-for-modulating-s1p5-for-treatment-of-neurological-diseases/ 2024-04-15T13:15:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/jounce-therapeutics-gets-grant-for-monoclonal-antibody-for-treating-cancer-by-binding-pd-1/ 2024-04-15T13:15:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/harrow-health-gets-grant-for-preservative-free-ophthalmic-composition-for-dry-eye-disease/ 2024-04-15T13:15:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/scripps-health-gets-grant-for-regenerating-cartilaginous-tissue-from-pluripotent-stem-cells/ 2024-04-15T13:15:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/oncopeptides-gets-grant-for-lyophilized-pharmaceutical-preparation-for-cancer-therapy/ 2024-04-15T13:15:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/synthon-international-holdings-gets-grant-for-pharmaceutical-composition-with-lenvatinib-mesylate-and-sodium-bicarbonate/ 2024-04-15T13:15:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/perrigo-co-gets-grant-for-infant-nutritional-composition-with-specific-components/ 2024-04-15T13:15:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/hanmi-pharmaceuticals-gets-grant-for-polymer-compound-for-binding-to-globulin-fc-region/ 2024-04-15T13:15:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/sino-biopharmaceutical-gets-grant-for-p2x3-and-or-p2x2-3-receptor-antagonist-for-disease-treatment/ 2024-04-15T13:15:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/23andme-gets-grant-for-anti-il-36-antibody-for-blocking-il-36-cytokine-signaling/ 2024-04-15T13:14:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/century-therapeutics-gets-grant-for-universal-chimeric-antigen-receptor-system-with-adaptable-receptor-specificity/ 2024-04-15T13:14:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ginkgo-bioworks-gets-grant-for-gene-therapy-composition-for-treating-npc1-using-aav-vectors/ 2024-04-15T13:14:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/portage-mulls-company-closure-pauses-enrolment-for-lead-clinical-programme/ 2024-04-15T12:58:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sanofi-advances-nk-cell-engager-to-phase-ii-for-blood-cancer-treatment/ 2024-04-15T11:09:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/glenmark-recall-blood-pressure/ 2024-04-15T09:30:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nxera-handok-pivlaz-supply/ 2024-04-15T09:23:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nigeria-meningitis-vaccine-men5cv/ 2024-04-15T07:49:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sahpra-kenvue-cough-syrup/ 2024-07-02T18:20:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/uk-charities-condemn-continued-drug-shortages/ 2024-04-12T16:55:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-approves-new-administration-routes-for-xcopri/ 2024-04-12T16:03:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/candel-wins-fda-orphan-drug-designation-for-pancreatic-cancer-drug/ 2024-04-12T15:43:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/century-secures-60m-in-stock-sale-and-buys-preclinical-cell-therapy-biotech/ 2024-04-18T10:03:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/moderna-kenya-mrna-facility/ 2024-04-12T10:37:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fujifilm-invests-1-2bn-ramping-up-north-carolina-facility/ 2024-04-12T10:52:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/eliem-to-acquire-tenet/ 2024-04-12T10:08:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novartis-enters-deal-arvinas/ 2024-04-12T09:09:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-astrazeneca-fasenra/ 2024-04-12T09:06:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/rallybio-and-jj-collaborate-to-tackle-maternal-foetal-blood-disorder/ 2024-04-12T08:24:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/uks-nice-recommends-abbvies-aquipta-to-treat-migraines/ 2024-04-11T16:03:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/vertex-joins-pharma-immunotherapy-deal-uptick-with-4-9bn-alpine-purchase/ 2024-04-11T15:02:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/surges-in-obesity-drugs-forecast-to-enter-us-market/ 2024-04-11T10:41:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ose-wins-french-govt-grant-for-phase-iii-trial-for-cancer-vaccine/ 2024-04-11T11:14:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/addressing-key-challenges-in-hpapi-manufacturing/ 2026-02-13T12:23:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/drug-delivery-innovations-push-forth-womens-health/ 2024-06-13T14:54:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/innate-pharma-plans-ind-of-adc-candidate-after-positive-preclinical-data/ 2024-04-10T15:17:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novartis-plans-to-axe-680-employees/ 2024-04-11T09:29:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/lisata-wins-fda-orphan-drug-status-for-bone-cancer-candidate/ 2024-04-10T14:07:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/torl-scores-158m-in-series-b2-to-advance-adc-cancer-therapies/ 2024-04-10T13:53:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/acceleron-pharma-gets-grant-for-treatment-of-spinal-muscular-atrophy-using-alk4-actriib-antagonists/ 2024-04-10T13:20:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/morphosys-gets-grant-for-novel-compounds-for-treating-diseases-associated-with-methyl-modifying-enzymes/ 2024-04-10T13:20:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/adma-biologics-gets-grant-for-treatment-of-upper-respiratory-tract-infection-with-immunotherapeutic-composition/ 2024-04-10T13:20:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/kyowa-kirin-gets-grant-for-monoclonal-antibody-inhibiting-ccr1-activation-by-ccl15/ 2024-04-10T13:20:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/aerie-pharmaceuticals-gets-grant-for-ocular-disorder-treatment-using-amino-isoquinolinyl-amide-compounds/ 2024-04-10T13:20:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/kala-pharmaceuticals-gets-grant-for-ocular-treatment-method-using-msc-derived-fibronectin-composition/ 2024-04-10T13:20:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/laboratorios-farmaceuticos-rovi-gets-grant-for-injectable-composition-for-treating-cancer-especially-breast-cancer/ 2024-04-10T13:20:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/adamas-pharmaceuticals-gets-grant-for-extended-release-amantadine-for-reducing-sleep-disturbances-in-parkinson-s-disease/ 2024-04-10T13:20:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/iqvia-gets-grant-for-method-for-identifying-influential-physicians-in-a-network/ 2024-04-10T13:20:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/adaptimmune-gets-grant-for-method-for-predicting-and-preventing-cross-reactivity-in-peptide-administration/ 2024-04-10T13:20:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/dicerna-pharmaceuticals-gets-grant-for-treating-lung-disease-by-reducing-a-1-antitrypsin-levels/ 2024-04-10T13:20:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/dong-a-socio-gets-grant-for-site-specific-labeling-of-antibodies-with-chemical-functional-groups/ 2024-04-10T13:20:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/h-lundbeck-gets-grant-for-modulators-of-abhd12-for-treating-cancer-and-infectious-diseases/ 2024-04-10T13:20:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/biorestorative-therapies-gets-grant-for-identifying-compounds-that-modify-metabolic-activity-of-human-brown-fat/ 2024-04-10T13:20:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/memorial-sloan-kettering-cancer-center-gets-grant-for-selecting-cancer-patients-for-cdk4-inhibitor-treatment/ 2024-04-10T13:20:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/biohaven-pharmaceutical-holding-gets-grant-for-pharmaceutical-composition-for-cancer-treatment-with-riluzole-prodrugs/ 2024-04-10T13:20:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/otsuka-gets-grant-for-customized-therapeutic-regimen-monitoring-system/ 2024-04-10T13:20:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/novozymes-gets-grant-for-xylanase-and-arabinofuranosidase-composition-for-animal-feed/ 2024-04-10T13:20:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/catalent-gets-grant-for-soft-gel-dosage-form-with-stable-concentrated-naproxen-formulation/ 2024-04-10T13:20:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/isoplexis-gets-grant-for-polymerase-enzyme-with-improved-nucleotide-incorporation-and-no-exonuclease-activity/ 2024-04-10T13:20:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/alkermes-gets-grant-for-treatment-of-cognitive-function-disorder-with-hdac-inhibitors/ 2024-04-10T13:20:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/theravance-biopharma-gets-grant-for-prodrugs-with-neprilysin-inhibition-activity/ 2024-04-10T13:20:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/verily-life-sciences-gets-grant-for-context-aware-recommendations-for-managing-chronic-health-conditions/ 2024-04-10T13:20:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/genscript-biotech-gets-grant-for-use-of-trehalase-in-fermentative-production-of-alcohol/ 2024-04-10T13:20:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/forty-seven-gets-grant-for-treatment-of-cd20-cancer-using-anti-cd47-antibody/ 2024-04-10T13:19:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/vor-biopharma-gets-grant-for-genetically-engineered-hematopoietic-cells-for-treating-acute-myeloid-leukemia/ 2024-04-10T13:19:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/phenomex-gets-grant-for-polymerase-enzyme-with-improved-nucleotide-incorporation-and-no-exonuclease-activity/ 2024-04-10T13:19:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/sanbio-gets-grant-for-cell-preparations-for-modulating-immune-functions-by-suppressing-th1-cells/ 2024-04-10T13:19:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/relay-therapeutics-gets-grant-for-solid-form-of-compound-i-1/ 2024-04-10T13:19:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/bridgebio-pharma-gets-grant-for-treatment-of-transthyretin-amyloid-disease-using-crystalline-form-type-a/ 2024-04-10T13:19:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/shattuck-labs-gets-grant-for-chimeric-protein-for-cancer-treatment/ 2024-04-10T13:19:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/eton-pharmaceuticals-gets-grant-for-oral-liquid-formulation-of-hydrocortisone/ 2024-04-10T13:19:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/idorsia-pharmaceutical-gets-grant-for-patent-granted-for-synthetic-oligosaccharide-for-klebsiella-pneumoniae-treatment/ 2024-04-10T13:19:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/oyster-point-pharma-gets-grant-for-treatment-of-dry-eye-disease-by-activating-trigeminal-nerve/ 2024-04-10T13:19:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/prevail-therapeutics-gets-grant-for-gene-therapy-for-gaucher-disease-using-raav-with-gcase-protein/ 2024-04-10T13:19:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/benevolentai-gets-grant-for-text-embedding-for-entities-and-relationships-using-machine-learning/ 2024-04-10T13:19:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/legend-biotech-gets-grant-for-constructs-with-single-domain-antibody-recognizing-tigit/ 2024-04-10T13:19:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/immunovant-gets-grant-for-anti-fcrn-antibody-with-improved-stability-for-autoimmune-disease-treatment/ 2024-04-10T13:19:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/compass-pathways-gets-grant-for-patent-granted-for-treating-anxiety-disorder-with-crystalline-psilocybin/ 2024-04-10T13:19:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/mirum-pharmaceuticals-gets-grant-for-treatment-of-cholestatic-pruritus-in-alagille-syndrome-with-maralixibat/ 2024-04-10T13:19:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/avantor-gets-grant-for-patent-granted-for-composition-with-specific-ingredients-for-various-uses/ 2024-04-10T13:19:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/soliton-gets-grant-for-apparatus-for-generating-therapeutic-shock-waves/ 2024-04-10T13:19:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/mind-medicine-mindmed-gets-grant-for-synthesizing-psychoactive-prodrugs-from-amino-acids/ 2024-04-10T13:19:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/acc-24-empact-mi-study-primary-endpoint-failure/ 2024-04-10T11:04:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/syros-tamibarotene-fda-aml/ 2024-04-10T10:37:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/lonza-neurosense-exosome-biomarkers/ 2024-04-10T10:39:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/transgene-and-necs-cancer-vaccine-shows-promise-in-head-and-neck-cancer/ 2024-05-10T15:57:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/acc24-semaglutide-heart-failure-hospitalisation/ 2024-04-10T09:45:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/bayer-google-cloud-ai-solutions/ 2024-04-10T08:15:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mhra-tmc-pharma-fosdenopterin/ 2024-04-10T08:03:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/oryzon-wins-fda-approval-to-begin-sclc-treatment-trial/ 2024-04-09T16:23:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/pfizer-meets-phase-iii-primary-endpoints-for-rsv-vaccine-abrysvo/ 2024-04-09T16:15:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/seaport-emerges-after-100m-raise-with-ex-karuna-team-at-helm/ 2024-04-09T15:57:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/brainstorm-new-trial-agree-fda-after-failure/ 2024-04-09T14:25:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/basilea-wins-carb-x-grant-for-new-antibody-development/ 2024-04-09T14:18:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/prothea-debuts-with-13m-to-develop-cancer-diagnostics-and-treatment/ 2024-04-09T10:44:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/prothea-debuts-with-13m-to-develop-cancer-diagnostics-and-treatment-2/ 2024-05-10T15:56:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-accepts-shorlas-oral-liquid-leukaemia-drug-nda/ 2024-04-08T15:19:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/pluris-launches-manufacturing-division-as-cell-therapy-pipeline-progresses/ 2024-04-09T15:01:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/jj-and-legends-carvykti-scores-early-line-approval-for-mm-by-fda/ 2024-04-08T14:52:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sensorion-raises-16m-for-gene-therapies-to-treat-deafness/ 2024-04-08T14:16:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/adalta-synthesis-adcella/ 2024-04-08T10:25:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/medicxi-starpharma-oncology/ 2024-04-08T10:18:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/bms-2seventy-bio-abecma/ 2024-04-08T08:56:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-daiichi-sankyo-astrazeneca-enhertu-2/ 2024-04-08T08:55:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/opinion/navigating-post-approval-research-and-reimbursement-for-orphan-therapies/ 2024-04-06T05:32:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/seagen-gets-grant-for-reduced-fucosylation-in-t-cells-for-cancer-treatment/ 2024-04-17T12:23:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/astrazeneca-reports-positive-phase-iii-results-for-imfinzi-in-small-cell-lung-cancer/ 2024-04-08T10:35:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gsk-expands-asia-pacific-reach-for-trelegy-ellipta-with-singapore-approval/ 2024-04-05T13:59:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/amylyx-axes-als-drug-from-market-after-phase-iii-failure/ 2024-04-05T13:01:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/englands-mmr-vaccinations-up-23-following-nhs-initiative/ 2024-04-05T12:10:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/acumen-lonza-alzheimers-sabirnetug/ 2024-04-05T10:37:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mina-nippon-rnaa-therapeutics/ 2024-04-05T10:18:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/caris-merck-adcs-cancer/ 2024-04-05T08:29:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/uk-mhra-advanz-pharma-antibiotic/ 2024-04-05T08:30:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/interviews/qa-barda-chief-says-agency-looks-to-back-tech-that-can-combat-multiple-infections/ 2024-04-05T13:50:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/touchlight-joins-forces-with-university-of-liverpool-for-nsclc-vaccine/ 2024-04-04T14:23:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/addex-spinoff-neurosterix-debuts-with-63m-for-developing-neurological-therapies/ 2024-04-04T14:21:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/lipocine-gets-grant-for-pharmaceutical-composition-for-treating-testosterone-deficiency/ 2024-04-04T13:04:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/united-therapeutics-gets-grant-for-treatment-of-pulmonary-hypertension-using-prostacyclin-treated-stem-cells/ 2024-04-04T13:04:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/xencor-gets-grant-for-bispecific-antibody-for-treating-gpc3-associated-cancers/ 2024-04-04T13:03:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/incyte-gets-grant-for-treatment-of-various-cancers-using-specific-compound/ 2024-04-04T13:03:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/hca-healthcare-gets-grant-for-wrist-brace-with-advantageous-lacing-configuration-for-compression/ 2024-04-04T13:03:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/chiesi-farmaceutici-gets-grant-for-pharmaceutical-formulation-for-intraduodenal-administration-with-melevodopa-and-carbidopa/ 2024-04-04T13:03:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/f-hoffmann-la-roche-gets-grant-for-system-for-identifying-nucleic-acid-bases-using-nanopore-technology/ 2024-04-04T13:02:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/anavex-life-sciences-gets-grant-for-treatment-of-neurodevelopmental-disorders-using-anavex2-73/ 2024-04-04T13:02:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/mannkind-gets-grant-for-dry-powder-composition-for-pulmonary-delivery-of-pde5-inhibitor/ 2024-04-04T13:02:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/intra-cellular-therapies-gets-grant-for-amorphous-solid-dispersion-of-iti-007-tosylate-salt/ 2024-04-04T13:02:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/zoetis-gets-grant-for-recombinant-viral-vectors-for-multivalent-pathogen-protection-in-vaccines/ 2024-04-04T13:01:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/grifols-gets-grant-for-sterilization-device-for-flexible-bags-containing-plasma-protein-solutions/ 2024-04-04T13:01:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/moderna-gets-grant-for-lipid-nanoparticle-for-il-12-mrna-cancer-treatment/ 2024-04-04T13:01:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/shionogi-gets-grant-for-pharmaceutical-composition-for-treating-chronic-cough/ 2024-04-04T13:01:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/astrazeneca-gets-grant-for-inhaler-with-trigger-mechanism-for-medicament-delivery/ 2024-04-04T13:00:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/abbvie-gets-grant-for-hif-1a-prolyl-hydroxylase-inhibitors-for-treating-cardiovascular-diseases/ 2024-04-04T13:00:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/bayer-gets-grant-for-medicament-for-cardiovascular-disorders-thrombotic-disorders-and-edemas/ 2024-04-04T13:00:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/bristol-myers-squibb-gets-grant-for-patent-granted-for-cancer-treatment-using-histone-demethylase-inhibitors/ 2024-04-04T12:59:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/dynavax-technologies-gets-grant-for-treatment-of-autoimmune-diseases-using-toll-like-receptor-antagonists/ 2024-04-04T12:59:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/insmed-gets-grant-for-treatment-of-gram-positive-pulmonary-bacterial-infections/ 2024-04-04T12:59:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/omeros-gets-grant-for-method-of-inhibiting-adverse-effects-of-liver-transplantation/ 2024-04-04T12:59:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cytomx-therapeutics-gets-grant-for-activatable-molecule-with-cleavable-moiety-substrate-for-matriptase/ 2024-04-04T12:58:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/sangamo-therapeutics-gets-grant-for-gene-inactivation-for-immune-function-retention-during-glucocorticoid-treatment/ 2024-04-04T12:58:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/takara-gets-grant-for-selective-separation-of-target-nucleic-acids-from-a-composition/ 2024-04-04T12:58:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/mimedx-group-gets-grant-for-kit-for-administering-compositions-of-modified-amniotic-fluid/ 2024-04-04T12:58:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/jiangsu-hengrui-medicine-gets-grant-for-combination-of-anti-pd-1-antibody-and-vegfr-inhibitor-for-cancer-treatment/ 2024-04-04T12:57:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/alpine-immune-sciences-gets-grant-for-variant-cd112-polypeptide-for-immunomodulation-in-immunological-conditions/ 2024-04-04T12:57:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/takeda-pharmaceutical-gets-grant-for-treatment-of-perianal-fistulizing-crohn-s-disease-with-humanized-antibody/ 2024-04-04T12:57:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/daiichi-sankyo-gets-grant-for-method-for-producing-compounds-with-spirooxindole-skeleton/ 2024-04-04T12:57:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ngm-biopharmaceuticals-gets-grant-for-treatment-method-using-glucagon-receptor-antagonist-and-immunotherapeutic-agent/ 2024-04-04T12:56:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/nektar-therapeutics-gets-grant-for-mixed-acid-salt-of-water-soluble-polymer-drug-conjugate/ 2024-04-04T12:56:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/mallinckrodt-gets-grant-for-clinical-decision-support-system-for-delivering-therapeutic-gas-to-patients/ 2024-04-04T12:56:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/bausch-health-gets-grant-for-topical-treatment-for-onychomycosis-using-specific-pharmaceutical-composition/ 2024-04-04T12:56:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/glenmark-pharmaceuticals-gets-grant-for-method-for-purifying-antibodies-from-cell-cultures/ 2024-04-04T12:55:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/regeneron-pharmaceuticals-gets-grant-for-antibodies-for-treating-diseases-associated-with-glp1r/ 2024-04-04T12:55:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/sage-therapeutics-gets-grant-for-treatment-of-cns-related-disorders-with-crystalline-form-c-of-compound-1/ 2024-04-04T12:55:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/hanmi-science-gets-grant-for-conjugate-for-obesity-treatment-with-oxyntomodulin-and-immunoglobulin/ 2024-04-04T12:55:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/bioatla-gets-grant-for-antibody-binding-to-ror2-protein/ 2024-04-04T12:54:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/jazz-pharmaceuticals-gets-grant-for-cbd-preparation-with-at-least-90-cbd-and-thc/ 2024-04-04T12:54:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/puretech-health-gets-grant-for-lymphatic-system-directing-lipid-prodrugs/ 2024-04-04T12:54:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/incannex-prepares-ind-submission-for-psychotherapy-asset/ 2024-04-04T14:23:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/obsidian-raises-160-5m-to-advance-til-cell-therapy-programme/ 2024-04-10T09:29:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/kintara-tuhura-merger-deal/ 2024-04-04T10:15:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/japan-partner-leukine-apap/ 2024-04-04T10:29:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/harnessing-pharmacovigilance-to-turn-reactive-investigation-into-active-discovery/ 2024-04-03T15:44:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/diagonal-antibodies-discovery-approach/ 2024-04-04T07:57:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/basilea-zevtera-fda-approval/ 2024-04-04T08:44:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/morris-dickson-will-distribute-mpox-vaccine-jynneos-in-the-us/ 2024-04-03T15:03:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/continuous-monitoring-expands-aseptic-knowledge-and-data-in-real-time/ 2024-04-03T13:03:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/genmab-joins-adc-arena-with-1-8bn-profoundbio-acquisition/ 2024-04-03T10:40:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/aditxt-adivir-appili-therapeutics/ 2024-04-03T10:51:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ec-bristol-myers-squibb-reblozyl/ 2024-04-03T10:51:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/china-nda-innovent-endometrial-cancer/ 2024-04-03T07:59:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-astrazeneca-daiichi-sankyo-bla/ 2024-04-03T08:34:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/bavarian-nordic-expands-access-to-mpox-vaccine-in-us/ 2024-04-02T16:04:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/partnerships-are-key-to-driving-digital-healthcare-transformation-in-us-say-experts/ 2024-04-22T10:09:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/can-digital-technology-address-us-healthcare-challenges/ 2024-04-22T10:07:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/proactive-data-driven-approach-to-closing-care-gaps-in-heart-disease/ 2024-04-10T08:18:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/mash-revival-innovator-drug-partnership-deals-in-2024/ 2024-04-02T13:29:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ipsen-joins-the-adc-club-with-deal-worth-up-to-900m/ 2024-04-02T13:23:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/lenmeldy-becomes-worlds-most-expensive-drug/ 2024-04-02T13:19:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/can-pharma-overcome-generative-ais-bias-problem/ 2024-04-02T12:30:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/merz-makes-a-185m-bid-for-assets-from-bankrupt-acorda/ 2024-04-02T13:42:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/overcoming-the-added-patient-burden-in-dcts/ 2024-04-02T11:00:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/xilio-fires-21-of-its-workforce-and-reprioritises-pipeline/ 2024-04-02T10:29:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/edenbridge-pantherx-yargesa/ 2024-04-02T10:19:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/cellenkos-mount-ck0804/ 2024-04-02T10:21:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/eisai-divest-rights-kaken/ 2024-04-02T09:02:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/alexions-voydeya-fda-haemolysis/ 2024-04-02T09:03:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/magazine-whats-next-for-aav-gene-therapies-in-2024/ 2024-03-20T13:06:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/eisai-and-biogen-move-to-bring-iv-dosing-for-leqembi-to-the-us/ 2024-04-01T16:34:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/novartis-gets-grant-for-treatment-of-cocaine-use-disorder-using-mavoglurant/ 2024-04-01T12:38:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/a-menarini-industrie-farmaceutiche-riunite-gets-grant-for-method-of-generating-massively-parallel-sequencing-library/ 2024-04-01T12:38:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/yuhan-gets-grant-for-high-speed-precise-temperature-control-for-gas-chromatography-columns/ 2024-04-01T12:37:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/lonza-group-gets-grant-for-patent-granted-for-capsule-composition-with-pullulan-setting-system-surfactant/ 2024-04-01T12:37:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/forma-therapeutics-gets-grant-for-usp30-inhibitor-compounds-for-medical-use/ 2024-04-01T12:37:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/gilead-sciences-gets-grant-for-treatment-of-hiv-infection-with-specific-compounds/ 2024-04-01T12:37:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ucb-gets-grant-for-treatment-of-systemic-lupus-erythematosus-with-anti-cd154-antibody/ 2024-04-01T12:36:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/jubilant-pharmova-gets-grant-for-radiopharmaceutical-composition-for-diagnostic-imaging-with-stable-attributes/ 2024-04-01T12:36:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/merck-gets-grant-for-patent-granted-for-tricyclic-heterocycle-compounds-for-treating-hiv/ 2024-04-01T12:36:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/redx-pharma-gets-grant-for-rock-inhibitors-for-treating-rock-mediated-diseases/ 2024-04-01T12:35:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/krystal-biotech-gets-grant-for-gene-therapy-for-vision-loss-using-hsv-1-virus/ 2024-04-01T12:35:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/praxis-precision-medicines-gets-grant-for-treatment-of-diseases-related-to-sodium-ion-channel-dysfunction/ 2024-04-01T12:35:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/wuxi-biologics-cayman-gets-grant-for-bispecific-polypeptide-complex-for-treating-diseases/ 2024-04-01T12:35:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/singular-genomics-systems-gets-grant-for-modified-archaeal-polymerases-for-improved-dna-sequencing/ 2024-04-01T12:34:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/dyne-therapeutics-gets-grant-for-muscle-targeting-complex-inhibiting-dux4-expression-with-oligonucleotide-payload/ 2024-04-01T12:34:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/kymera-therapeutics-gets-grant-for-treatment-of-myd88-mutant-b-cell-lymphomas-using-irak4-degrader/ 2024-04-01T12:34:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/tonix-pharmaceuticals-holding-gets-grant-for-patent-granted-for-eutectic-of-cyclobenzaprine-hcl-and-mannitol/ 2024-04-01T12:34:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/kinnate-biopharma-gets-grant-for-inhibitors-of-raf-for-disease-treatment/ 2024-04-01T12:33:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/eisai-gets-grant-for-method-for-treating-tumor-expressing-neuropilin-1-with-chlorotoxin-agent/ 2024-04-01T12:33:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/endo-international-gets-grant-for-patent-granted-for-recombinant-nucleic-acid-encoding-collagenase/ 2024-04-01T12:33:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/blueprint-medicines-gets-grant-for-treatment-of-ret-altered-non-small-cell-lung-cancer/ 2024-04-01T12:33:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/sutro-biopharma-gets-grant-for-compound-according-to-formula-1000-for-cancer-treatment/ 2024-04-01T12:32:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/akebia-therapeutics-gets-grant-for-treating-anemia-with-specific-doses-of-hif-prolyl-hydroxylase-inhibitor/ 2024-04-01T12:32:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/glycomimetics-gets-grant-for-treatment-and-prevention-of-diseases-by-inhibiting-e-selectin-binding/ 2024-04-01T12:32:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/piramal-enterprises-gets-grant-for-pharmaceutical-kit-for-melanoma-treatment-with-cdk-inhibitor/ 2024-04-01T12:32:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/acura-pharmaceuticals-gets-grant-for-abuse-deterrent-pharmaceutical-composition-with-delayed-release-mechanism/ 2024-04-01T12:31:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/sosei-group-gets-grant-for-agonists-of-muscarinic-m1-or-m1-m4-receptors/ 2024-04-01T12:31:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/heron-therapeutics-gets-grant-for-patent-granted-for-injectable-emulsion-for-preventing-post-operative-nausea/ 2024-04-01T12:31:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/novan-gets-grant-for-topical-pharmaceutical-composition-with-nitric-oxide-releasing-co-condensed-silica-particles/ 2024-04-01T12:31:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/silence-therapeutics-gets-grant-for-nucleic-acid-for-inhibiting-target-gene-expression/ 2024-04-01T12:30:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/nanobiotix-gets-grant-for-treatment-of-solid-tumor-cancer-using-inorganic-nanoparticles/ 2024-04-01T12:30:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/united-laboratories-international-gets-grant-for-method-for-removing-hydrogen-sulfide-using-methylmorpholine-n-oxide-solution/ 2024-04-01T12:30:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/eurofins-scientific-gets-grant-for-predicting-cancer-immunotherapy-response-based-on-tcr-diversity/ 2024-04-01T12:29:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/biomarin-pharmaceutical-gets-grant-for-recombinant-adeno-associated-virus-for-gene-therapy/ 2024-04-01T12:29:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/purdue-pharma-gets-grant-for-parenteral-formulation-for-rapid-opioid-overdose-treatment/ 2024-04-01T12:29:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/natco-pharma-gets-grant-for-high-purity-process-for-preparing-sugammadex-sodium-formula/ 2024-04-01T12:29:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/grunenthal-gets-grant-for-abuse-proofed-oral-dosage-form-with-controlled-opioid-release/ 2024-04-01T12:28:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/genexine-gets-grant-for-treatment-of-hpv-induced-cancer-using-hpv-vaccine-and-checkpoint-inhibitor/ 2024-04-01T12:28:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/teladoc-health-gets-grant-for-automated-generation-of-structured-medical-notes-during-remote-consultations/ 2024-04-01T12:28:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/us-fda-alebunds-ap303/ 2024-04-01T11:20:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-track-liscures-lb-p8/ 2024-04-01T10:43:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gileads-vemlidy-expands-label-to-treat-paediatric-chronic-hbv/ 2024-03-29T13:49:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/arvinas-gets-grant-for-treatment-of-prostate-cancer-with-specific-compounds/ 2024-03-29T11:45:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/csl-gets-grant-for-method-of-reducing-gvhd-risk-in-hct-patients-with-a1at/ 2024-03-29T11:45:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/chong-kun-dang-pharmaceutical-gets-grant-for-injectable-composition-of-testosterone-undecanoate-for-testosterone-deficiency-treatment/ 2024-03-29T11:45:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/angelini-gets-grant-for-method-for-labelling-reels-using-robot-and-application-roller/ 2024-03-29T11:44:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/rohto-pharmaceutical-gets-grant-for-ophthalmic-composition-for-treating-myopia-with-crocetin-and-ginkgo-leaf/ 2024-03-29T11:44:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ptc-therapeutics-gets-grant-for-treatment-of-huntington-s-disease-using-compound-of-formula-ibbl/ 2024-03-29T11:44:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/gamida-cell-gets-grant-for-method-of-preparing-transplantable-nk-cell-fraction-for-transplantation/ 2024-03-29T11:44:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/crinetics-pharmaceuticals-gets-grant-for-patent-granted-for-somatostatin-modulators-for-treating-hormone-related-conditions/ 2024-03-29T11:43:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/yield10-bioscience-gets-grant-for-genetically-engineered-oilseed-plant-expressing-plant-protein/ 2024-03-29T11:43:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/sun-pharmaceutical-industries-gets-grant-for-dermal-patch-system-for-collecting-physiological-samples/ 2024-03-29T11:43:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/zealand-pharma-gets-grant-for-novel-acylated-glucagon-analogue-peptides-for-treating-metabolic-disorders/ 2024-03-29T11:43:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/enanta-pharmaceuticals-gets-grant-for-inhibiting-coronavirus-replication-with-compound-of-formula-i/ 2024-03-29T11:42:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/indivior-gets-grant-for-medication-component-mixing-system-with-female-and-male-syringes/ 2024-03-29T11:42:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/sorrento-therapeutics-gets-grant-for-transdermal-drug-delivery-device-with-microneedle-assembly-and-reservoir/ 2024-03-29T11:42:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/senju-pharmaceutical-gets-grant-for-composition-for-treating-corneal-endothelial-conditions/ 2024-03-29T11:41:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/precigen-gets-grant-for-splice-control-module-for-sex-specific-gene-expression-in-insects/ 2024-03-29T11:41:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/zeria-pharmaceutical-gets-grant-for-method-for-preparing-solid-oral-dosage-forms-with-antibodies-coating/ 2024-03-29T11:41:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/argenx-gets-grant-for-neutralizing-il-6-activity-using-specific-antibodies/ 2024-03-29T11:41:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/orexo-gets-grant-for-patent-granted-for-solid-pharmaceutical-composition-for-nasal-naloxone-delivery/ 2024-03-29T11:40:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/contrafect-gets-grant-for-intranasal-or-inhalation-administration-of-antibodies-for-influenza-treatment/ 2024-03-29T11:40:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/biogaia-gets-grant-for-therapeutic-microvesicles-from-probiotic-bacteria/ 2024-03-29T11:40:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ardelyx-gets-grant-for-compound-for-treating-hyperkalemia-by-inhibiting-enzyme-11-hsd2/ 2024-03-29T11:40:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/immunogen-gets-grant-for-method-of-preparing-cell-binding-agent-cytotoxic-agent-conjugate/ 2024-03-29T11:39:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/shilpa-medicare-gets-grant-for-pharmaceutical-liposomal-composition-with-docetaxel-for-cancer-treatment/ 2024-03-29T11:39:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/zhejiang-huahai-pharmaceutical-gets-grant-for-method-for-continuously-preparing-citalopram-diol/ 2024-03-29T11:39:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/iovance-biotherapeutics-gets-grant-for-gene-edited-til-composition-with-enhanced-therapeutic-efficacy/ 2024-03-29T11:39:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/protagonist-therapeutics-gets-grant-for-peptide-inhibitors-for-treating-inflammatory-bowel-disease/ 2024-03-29T11:38:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/eli-lilly-and-co-gets-grant-for-patent-granted-for-nasal-drug-delivery-device/ 2024-03-29T11:38:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/iveric-bio-gets-grant-for-carbocyclic-prolinamide-derivatives-for-treating-age-related-macular-degeneration/ 2024-03-29T11:38:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/zevra-therapeutics-gets-grant-for-crystalline-form-of-emetine-dihydrochloride/ 2024-03-29T11:38:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/teva-pharmaceutical-industries-gets-grant-for-breath-actuated-inhaler-with-dose-counter-and-variable-forces/ 2024-03-29T11:37:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/elanco-animal-health-gets-grant-for-reducing-ammonia-and-carbon-dioxide-emissions-from-bovines/ 2024-03-29T11:37:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/radius-health-gets-grant-for-combination-treatment-for-estrogen-dependent-cancers-using-rad1901-and-everolimus/ 2024-03-29T11:37:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/gsk-gets-grant-for-liposomal-rna-immunization-for-eliciting-antibody-response/ 2024-03-29T11:37:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/voyager-therapeutics-gets-grant-for-enhanced-aav-capsid-for-brain-cell-targeting/ 2024-03-29T11:36:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/pmv-pharmaceuticals-gets-grant-for-restoring-wild-type-function-to-p53-mutants-in-cancer/ 2024-03-29T11:36:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/avidity-biosciences-gets-grant-for-treatment-of-muscle-atrophy-or-myotonic-dystrophy-using-sirna/ 2024-03-29T11:36:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/wave-life-sciences-gets-grant-for-improved-method-for-synthesizing-phosphoramidites-with-higher-yields-and-purities/ 2024-03-29T11:36:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/aldeyra-therapeutics-gets-grant-for-treatment-of-diseases-involving-aldehyde-toxicity-using-primary-amines/ 2024-03-29T11:35:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/arcellx-gets-grant-for-patent-granted-for-d-domain-polypeptide-binding-cd123/ 2024-03-29T11:35:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/china-astellas-urothelial-cancer/ 2024-03-29T09:14:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-applied-therapeutics-nda/ 2024-03-29T09:13:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/intravacc-primrose-vaccine-development/ 2024-03-29T07:30:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ec-merck-keytruda-regimen/ 2024-03-29T07:26:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/buyers-guide/pharma-compounding-companies-contract-marketing/ 2024-04-02T11:58:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/realta-signs-deal-with-niaid-to-develop-drug-for-radiation-poisoning/ 2024-03-28T17:02:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/buyers-guide/lab-equipment-procurement/ 2024-03-28T16:06:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/measles-cases-continue-to-rise-in-us-amid-lagging-vaccination-rates/ 2024-03-28T16:00:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/nanoscope-therapeutics-positive-top-line-phase-iib-results-mco-010/ 2024-03-28T15:46:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/crispr-drug-licensing-deals/ 2024-04-06T05:31:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/xilio-and-gilead-partner-up-for-il-12-therapeutic-development/ 2024-03-28T15:21:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/cheap-drugs-inspections-future-war-europe-drug-shortages/ 2024-03-28T15:03:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/boundless-bio-raises-100m-as-ipo-market-rouses/ 2024-03-28T14:02:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ose-immunotherapeutics-gets-grant-for-anti-human-sirpa-antibody-for-treating-cancer/ 2024-03-28T13:19:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cidara-therapeutics-gets-grant-for-conjugates-for-treating-viral-infections/ 2024-03-28T13:19:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/synlogic-gets-grant-for-genetically-engineered-bacteria-for-treating-phenylketonuria/ 2024-03-28T13:18:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/abivax-gets-grant-for-antitumor-pharmaceutical-combination-for-cancer-treatment/ 2024-03-28T13:18:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/4d-molecular-therapeutics-gets-grant-for-recombinant-aav-for-muscle-cell-infectivity-with-heterologous-peptide/ 2024-03-28T13:18:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/atea-pharmaceuticals-gets-grant-for-treatment-of-covid-19-using-purine-nucleotide-phosphoramidates/ 2024-03-28T13:18:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/spruce-biosciences-gets-grant-for-treatment-of-polycystic-ovary-syndrome-with-adrenal-hyperandrogenism/ 2024-03-28T13:17:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/pieris-pharmaceuticals-gets-grant-for-patent-granted-for-novel-muteins-derived-from-human-lipocalin/ 2024-03-28T13:17:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/lantern-pharma-gets-grant-for-treatment-of-atypical-teratoid-rhabdoid-tumor-using-hydroxyureamethyl-acylfulvene/ 2024-03-28T13:17:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/denali-therapeutics-gets-grant-for-proteins-for-treating-sanfilippo-syndrome-a/ 2024-03-28T13:16:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ikena-oncology-gets-grant-for-mek-inhibitors-for-cancer-treatment/ 2024-03-28T13:16:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cue-biopharma-gets-grant-for-t-cell-modulatory-multimeric-polypeptides-for-immune-response-modulation/ 2024-03-28T13:16:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/equillium-gets-grant-for-inhibitors-of-c-cytokine-activity-using-peptide-antagonists/ 2024-03-28T13:16:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/prometheus-biosciences-gets-grant-for-anti-cd30l-antibodies-for-autoimmune-disease-treatment/ 2024-03-28T13:15:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/foghorn-therapeutics-gets-grant-for-compounds-for-treating-baf-complex-related-disorders/ 2024-03-28T13:15:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/aligos-therapeutics-gets-grant-for-treatment-of-disease-using-compounds-of-formula-i/ 2024-03-28T13:15:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/kobayashi-pharmaceutical-gets-grant-for-pharmaceutical-composition-container-with-lidocaine-suppression/ 2024-03-28T13:15:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cytokinetics-gets-grant-for-formulation-of-omecamtiv-mecarbil-for-pharmaceutical-use/ 2024-03-28T13:14:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/vericel-gets-grant-for-composition-for-repairing-cartilage-defects-using-cultured-allogeneic-cells/ 2024-03-28T13:14:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/kodiak-sciences-gets-grant-for-random-copolymers-containing-zwitterions-and-functional-agents/ 2024-03-28T13:14:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/northwest-biotherapeutics-gets-grant-for-method-for-deriving-immature-dendritic-cells-from-monocytic-precursors/ 2024-03-28T13:14:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/molecular-partners-gets-grant-for-multi-specific-protein-for-treating-cancer-by-targeting-different-antigens/ 2024-03-28T13:13:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/nurix-therapeutics-gets-grant-for-degradation-of-btk-using-compound-of-formula-a/ 2024-03-28T13:13:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/genmab-gets-grant-for-patent-granted-for-novel-bispecific-antibodies-production-methods/ 2024-03-28T13:13:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/fortress-biotech-gets-grant-for-treatment-of-cancer-using-antibodies-binding-to-pd-l1/ 2024-03-28T13:12:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/zhejiang-hisun-pharmaceutical-gets-grant-for-pyrimidine-derivative-for-treating-diseases-of-fgfr4-over-expression/ 2024-03-28T13:12:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/epivax-gets-grant-for-inducing-regulatory-t-cells-to-suppress-immune-response/ 2024-03-28T13:12:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/bluebird-bio-gets-grant-for-deriving-additional-features-from-input-data-using-semantic-information/ 2024-03-28T13:12:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/therapeuticsmd-gets-grant-for-progesterone-formulations-with-reduced-dosage-for-oral-administration/ 2024-03-28T13:11:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/verastem-gets-grant-for-dual-raf-mek-inhibitor-for-cancer-treatment-in-oral-form/ 2024-03-28T13:11:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/lixte-biotechnology-gets-grant-for-in-vivo-delivery-of-endothall-to-cancer-cells/ 2024-03-28T13:11:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/medicinova-gets-grant-for-ibudilast-higher-dosage-oral-tablet-or-capsule-formulations/ 2024-03-28T13:11:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ironwood-pharmaceuticals-gets-grant-for-process-for-preparing-sgc-stimulators-in-high-purity/ 2024-03-28T13:10:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/innate-pharma-gets-grant-for-therapeutic-antibody-conjugated-to-1-6-glucan-oligomers/ 2024-03-28T13:10:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/trevena-gets-grant-for-pharmaceutical-process-for-preparing-compound-of-formula-i/ 2024-03-28T13:10:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/arrowhead-pharmaceuticals-gets-grant-for-rnai-agents-for-treating-diseases-associated-with-aat-deficiency/ 2024-03-28T13:10:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/inhibrx-gets-grant-for-multispecific-polypeptide-construct-with-dual-effector-functions/ 2024-03-28T13:09:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/acer-therapeutics-gets-grant-for-crystalline-form-of-emetine-dihydrochloride/ 2024-03-28T13:09:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/haisco-pharmaceutical-group-files-patent-for-pharmaceutical-salt-of-compound-for-degrading-btk/ 2024-03-28T13:09:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/seyltx-buys-algernons-phase-ii-chronic-cough-therapy/ 2024-05-10T15:56:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/gen-ai-and-its-use-in-medical-devices-and-samd/ 2024-04-22T09:54:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/otsuka-lundbeck-schizophrenia/ 2024-03-28T11:15:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/akebia-vafseo-fda-approval-ckd/ 2024-03-28T11:15:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/blackstone-moderna-flu-programme/ 2024-04-10T09:29:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/japan-astrazeneca-truqap-combo/ 2024-03-28T10:00:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-non-infectious-uveitis/ 2024-04-01T05:24:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-choroidal-disease/ 2024-04-01T05:23:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-bipolar-i-disorder/ 2024-04-01T05:23:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-mixed-pain-nociceptive-pain-neuropathic-pain/ 2024-04-01T05:23:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-somatic-pain/ 2024-04-01T05:23:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-nociceptive-pain/ 2024-04-01T05:22:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-primary-mediastinal-b-cell-lymphoma/ 2024-04-01T05:22:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-tenosynovial-giant-cell-tumor/ 2024-04-01T05:22:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-stem-cell-transplantation/ 2024-04-01T05:21:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-lentivirus-infections/ 2024-04-01T05:21:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-retroviridae-infections/ 2024-04-01T05:21:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-lyssavirus-infections/ 2024-04-01T05:21:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-rhabdoviridae-infections/ 2024-04-01T05:20:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-pneumovirus-infections/ 2024-04-01T05:20:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-paramyxoviridae-infections/ 2024-04-01T05:20:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-papillomaviridae-infections/ 2024-04-01T05:19:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-orthohepadnavirus-infections/ 2024-04-01T05:19:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-hepadnaviridae-infections/ 2024-04-01T05:19:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-togaviridae-infections/ 2024-04-01T05:19:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-filoviridae-infections/ 2024-04-01T05:18:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-varicellovirus-infections/ 2024-04-01T05:18:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-hepacivirus-infections/ 2024-04-01T05:18:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-flavivirus-infections/ 2024-04-01T05:17:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-flaviviridae-infections/ 2024-04-01T05:17:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-autism-spectrum-disorder-asd/ 2024-04-01T05:17:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-developmental-disorders/ 2024-04-01T05:17:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-bone-disorders/ 2024-04-01T05:16:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-recurrent-glioblastoma-multiforme-gbm/ 2024-04-01T05:16:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-upper-limb-muscle-spasticity/ 2024-04-01T05:16:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-metastatic-adenocarcinoma-of-the-pancreas/ 2024-04-01T05:15:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-giant-cell-arteritis-temporal-arteritis-cranial-arteritis-horton-disease/ 2024-04-01T05:15:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-ductal-carcinoma-in-situ/ 2024-04-01T05:15:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-arthritis-pain/ 2024-04-01T05:15:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-hemophagocytic-lymphohistiocytosis/ 2024-04-01T05:14:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-ductal-carcinoma/ 2024-04-01T05:14:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-non-small-cell-lung-carcinoma/ 2024-04-01T05:14:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-ocular-melanoma/ 2024-04-01T05:13:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-renal-failure/ 2024-04-01T05:13:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-metastatic-biliary-tract-cancer/ 2024-04-01T05:13:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-metastatic-bile-duct-cancer/ 2024-04-01T05:13:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-amyloid-cardiomyopathy/ 2024-04-01T05:12:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-lupus-erythematosus/ 2024-04-01T05:12:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-opium-withdrawal-syndrome/ 2024-04-01T05:12:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-traumatic-pain/ 2024-04-01T05:11:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-refractory-chronic-lymphocytic-leukemia-cll/ 2024-04-01T05:11:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-relapsed-chronic-lymphocytic-leukemia-cll/ 2024-04-01T05:11:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-metastatic-transitional-urothelial-tract-cancer/ 2024-04-01T05:11:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-plant-allergy/ 2024-04-01T05:10:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-peripheral-neuropathic-pain/ 2024-04-01T05:10:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-relapsing-multiple-sclerosis-rms/ 2024-04-01T05:10:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-peripheral-t-cell-lymphomas-ptcl/ 2024-04-01T05:09:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-skin-and-skin-structure-infections-sssi/ 2024-04-01T05:09:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-musculoskeletal-inflammation/ 2024-04-01T05:09:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-swine-influenza/ 2024-04-01T05:09:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-drug-toxicity/ 2024-04-01T05:08:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-pleural-effusion/ 2024-04-01T05:08:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-liposarcoma/ 2024-04-01T05:08:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-non-rhabdomyosarcoma/ 2024-04-01T05:07:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-metastatic-renal-cell-carcinoma/ 2024-04-01T05:07:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-metastatic-ovarian-cancer/ 2024-04-01T05:07:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-bone-sarcoma/ 2024-04-01T05:07:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-picornaviridae-infections/ 2024-04-01T05:06:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-anaplastic-large-cell-lymphoma-alcl/ 2024-04-01T05:06:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-upper-respiratory-tract-disorders/ 2024-04-01T05:06:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-respiratory-tract-inflammatory-disorders/ 2024-04-01T05:05:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-interstitial-lung-fibrosis/ 2024-04-01T05:05:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-lung-disease/ 2024-04-01T05:05:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-malignant-pleural-mesothelioma/ 2024-04-01T05:05:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-benign-tumor/ 2024-04-01T05:04:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-diabetic-complications/ 2024-04-01T05:04:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-poxviridae-infections/ 2024-04-01T05:04:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-cutaneous-mycosis/ 2024-04-01T05:03:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-hemangiomas/ 2024-04-01T05:03:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-clostridium-tetani-infections/ 2024-04-01T05:03:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-neisseria-infections/ 2024-04-01T05:02:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-borrelia-burgdorferi-infections/ 2024-04-01T05:01:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-bordetella-infections/ 2024-04-01T05:01:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-diabetic-neuropathic-pain/ 2024-04-01T05:01:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-posterior-uveitis/ 2024-04-01T05:00:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-wet-neovascular-exudative-macular-degeneration/ 2024-04-01T05:00:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-non-proliferative-diabetic-retinopathy-npdr/ 2024-04-01T05:00:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-type-i-hypersensitivity/ 2024-04-01T05:00:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-hypersensitivity/ 2024-04-01T04:59:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-sudoriferous-sweat-gland-disorders/ 2024-04-01T04:59:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-febrile-neutropenia/ 2024-04-01T04:59:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-amino-acid-metabolism-disorders/ 2024-04-01T04:58:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-mutational-disorders/ 2024-04-01T04:58:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-x-chromosome-disorders/ 2024-04-01T04:58:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-chromosomal-disorders/ 2024-04-01T04:58:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-spinal-cord-disorders/ 2024-04-01T04:57:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-disruptive-behavior-disorder/ 2024-04-01T04:57:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-mucopolysaccharidosis/ 2024-04-01T04:57:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-idiopathic-inflammatory-myopathy-iim/ 2024-04-01T04:56:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-inherited-metabolic-disorders/ 2024-04-01T04:56:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-cerebrovascular-disease/ 2024-04-01T04:56:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-lipid-disorders/ 2024-04-01T04:56:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-mycobacterium-infections/ 2024-04-01T04:55:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-cardiomyopathy/ 2024-04-01T04:55:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-allergic-rhino-conjunctivitis/ 2024-04-01T04:54:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-staphylococcus-aureus-infections/ 2024-04-01T04:55:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-vulvovaginal-candidiasis/ 2024-04-01T04:54:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-vision-disorders/ 2024-04-01T04:54:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-borrelia-infections/ 2024-04-01T04:53:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-enterobacteriaceae-infections/ 2024-04-01T04:53:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-polyneuropathies/ 2024-04-01T04:53:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-bacteremia/ 2024-04-01T04:53:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-post-partum-depression-maternal-depression-postnatal-depression/ 2024-04-01T04:52:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-demyelinating-diseases/ 2024-04-01T04:52:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-paraganglioma-glomus-jugulare-tumor/ 2024-04-01T04:51:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-keratitis/ 2024-04-01T04:52:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-mycoses/ 2024-04-01T04:51:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-protozoal-infection/ 2024-04-01T04:51:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-cytopenia/ 2024-04-01T04:50:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-bordetella-pertussis-infections/ 2024-04-01T04:51:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-bacterial-pneumonia/ 2024-04-01T04:50:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-hypersecretory-conditions/ 2024-04-01T04:50:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-pulmonary-fibrosis/ 2024-04-01T04:49:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-idiopathic-pulmonary-fibrosis/ 2024-04-01T04:49:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-obstructive-pulmonary-disease/ 2024-04-01T04:49:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-chronic-obstructive-pulmonary-disease-copd/ 2024-04-01T04:49:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-salmonella-typhi-infections/ 2024-04-01T04:48:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-respiratory-distress-syndrome/ 2024-04-01T04:48:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-esophagitis/ 2024-04-01T04:47:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-salmonella-infections/ 2024-04-01T04:48:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-cholestasis/ 2024-04-01T04:47:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-esophageal-diseases/ 2024-04-01T04:47:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-hypersomnia/ 2024-04-01T04:46:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-back-pain/ 2024-04-01T04:47:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-acute-ischemic-stroke/ 2024-04-01T04:46:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-generalized-seizures/ 2024-04-01T04:46:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-arteritis/ 2024-04-01T04:45:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-stroke/ 2024-04-01T04:45:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-shock/ 2024-04-01T04:44:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-cardiovascular-inflammation/ 2024-04-01T04:45:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-ocular-pain-eye-pain/ 2024-04-01T04:44:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-congestive-heart-failure-heart-failure/ 2024-04-01T04:44:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-cryopyrin-associated-periodic-syndromes/ 2024-04-01T04:43:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-complicated-intra-abdominal-infections/ 2024-04-01T04:44:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-respiratory-tract-infections/ 2024-04-01T04:43:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-labor-and-delivery/ 2024-04-01T04:43:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-diphtheria/ 2024-04-01T04:42:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-pneumonia/ 2024-04-01T04:42:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-apnea/ 2024-04-01T04:42:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-cough/ 2024-04-01T04:42:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-eye-infections/ 2024-04-01T04:41:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-hematopoietic-stem-cell-transplantation/ 2024-04-01T04:41:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-sezary-syndrome/ 2024-04-01T04:40:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-waldenstrom-macroglobulinemia-lymphoplasmacytic-lymphoma/ 2024-04-01T04:41:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-sphingolipidoses/ 2024-04-01T04:40:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-cutaneous-t-cell-lymphoma/ 2024-04-01T04:40:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-enterovirus-infections/ 2024-04-01T04:39:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-lipid-storage-disorders-lipidoses/ 2024-04-01T04:40:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-orthomyxoviridae-infections/ 2024-04-01T04:39:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-warts/ 2024-04-01T04:39:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-clostridium-infections/ 2024-04-01T04:38:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-neisseriaceae-infections/ 2024-04-01T04:38:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-gram-positive-bacterial-infections/ 2024-04-01T04:38:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-gram-negative-bacterial-infections/ 2024-04-01T04:38:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-burns/ 2024-04-01T04:37:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-staphylococcal-infections/ 2024-04-01T04:37:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-major-depressive-disorder/ 2024-04-01T04:36:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-nonmelanomatous-skin-cancer/ 2024-04-01T04:37:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-age-related-macular-degeneration/ 2024-04-01T04:36:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-dystonia/ 2024-04-01T04:36:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-human-papillomavirus-infections/ 2024-04-01T04:35:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-osteosarcoma/ 2024-04-01T04:36:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-urinary-tract-infections/ 2024-04-01T04:35:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-herpesviridae-infections/ 2024-04-01T04:35:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-osteoarthritis-pain/ 2024-04-01T04:34:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-thrombocythemia-myelofibrosis/ 2024-04-01T04:34:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/likelihood-of-approval-anesthetic-effect/ 2024-04-01T04:34:02+00:00 daily 0.2